EP2095100A1 - High-sensitivity nanoscale wire sensors - Google Patents
High-sensitivity nanoscale wire sensorsInfo
- Publication number
- EP2095100A1 EP2095100A1 EP07873479A EP07873479A EP2095100A1 EP 2095100 A1 EP2095100 A1 EP 2095100A1 EP 07873479 A EP07873479 A EP 07873479A EP 07873479 A EP07873479 A EP 07873479A EP 2095100 A1 EP2095100 A1 EP 2095100A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- nanoscale wire
- nanoscale
- wire
- analyte
- reaction entity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000002070 nanowire Substances 0.000 title claims abstract description 371
- 238000000034 method Methods 0.000 claims abstract description 91
- 239000012491 analyte Substances 0.000 claims abstract description 80
- 238000012216 screening Methods 0.000 claims abstract description 31
- 238000006243 chemical reaction Methods 0.000 claims description 86
- 230000008859 change Effects 0.000 claims description 56
- 239000004065 semiconductor Substances 0.000 claims description 52
- 150000007523 nucleic acids Chemical class 0.000 claims description 25
- 108020004707 nucleic acids Proteins 0.000 claims description 24
- 102000039446 nucleic acids Human genes 0.000 claims description 24
- 229910052710 silicon Inorganic materials 0.000 claims description 24
- 108090000623 proteins and genes Proteins 0.000 claims description 23
- 102000004169 proteins and genes Human genes 0.000 claims description 22
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000010703 silicon Substances 0.000 claims description 20
- 102000004190 Enzymes Human genes 0.000 claims description 19
- 108090000790 Enzymes Proteins 0.000 claims description 19
- 238000002493 microarray Methods 0.000 claims description 6
- 230000035945 sensitivity Effects 0.000 abstract description 25
- 239000000969 carrier Substances 0.000 abstract description 10
- 239000000523 sample Substances 0.000 description 67
- 239000000758 substrate Substances 0.000 description 48
- 230000027455 binding Effects 0.000 description 44
- 239000000463 material Substances 0.000 description 43
- 239000000203 mixture Substances 0.000 description 42
- 239000012530 fluid Substances 0.000 description 35
- 239000000243 solution Substances 0.000 description 35
- 229910052751 metal Inorganic materials 0.000 description 33
- 239000002184 metal Substances 0.000 description 33
- 239000002019 doping agent Substances 0.000 description 28
- 239000003792 electrolyte Substances 0.000 description 27
- 230000003993 interaction Effects 0.000 description 27
- 241000894007 species Species 0.000 description 27
- 108010072866 Prostate-Specific Antigen Proteins 0.000 description 26
- 102000007066 Prostate-Specific Antigen Human genes 0.000 description 26
- 239000003795 chemical substances by application Substances 0.000 description 22
- 238000001514 detection method Methods 0.000 description 19
- 239000000126 substance Substances 0.000 description 19
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 18
- 229940088598 enzyme Drugs 0.000 description 18
- 239000002086 nanomaterial Substances 0.000 description 17
- 239000002071 nanotube Substances 0.000 description 17
- 229920000642 polymer Polymers 0.000 description 16
- 229910052814 silicon oxide Inorganic materials 0.000 description 16
- -1 DNA or RNA) Chemical class 0.000 description 14
- 230000006870 function Effects 0.000 description 14
- 230000000670 limiting effect Effects 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 12
- 102000005962 receptors Human genes 0.000 description 11
- 108020003175 receptors Proteins 0.000 description 11
- 108090000765 processed proteins & peptides Proteins 0.000 description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 9
- 241000700605 Viruses Species 0.000 description 9
- 229910052796 boron Inorganic materials 0.000 description 9
- 238000002474 experimental method Methods 0.000 description 9
- 229910052732 germanium Inorganic materials 0.000 description 9
- 239000010410 layer Substances 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- 239000002105 nanoparticle Substances 0.000 description 9
- 238000001139 pH measurement Methods 0.000 description 9
- 230000004044 response Effects 0.000 description 9
- 238000004891 communication Methods 0.000 description 8
- 230000000295 complement effect Effects 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 239000003814 drug Substances 0.000 description 8
- 229940000406 drug candidate Drugs 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 230000001965 increasing effect Effects 0.000 description 8
- 230000004048 modification Effects 0.000 description 8
- 238000012986 modification Methods 0.000 description 8
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 7
- 150000001299 aldehydes Chemical class 0.000 description 7
- 238000004458 analytical method Methods 0.000 description 7
- 238000003491 array Methods 0.000 description 7
- 150000001720 carbohydrates Chemical class 0.000 description 7
- 235000014633 carbohydrates Nutrition 0.000 description 7
- 229910052799 carbon Inorganic materials 0.000 description 7
- 239000003446 ligand Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000011669 selenium Substances 0.000 description 7
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 230000008878 coupling Effects 0.000 description 6
- 238000010168 coupling process Methods 0.000 description 6
- 238000005859 coupling reaction Methods 0.000 description 6
- 239000013078 crystal Substances 0.000 description 6
- 238000009826 distribution Methods 0.000 description 6
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 230000009871 nonspecific binding Effects 0.000 description 6
- 239000002096 quantum dot Substances 0.000 description 6
- 229910052711 selenium Inorganic materials 0.000 description 6
- 239000002109 single walled nanotube Substances 0.000 description 6
- 229910052714 tellurium Inorganic materials 0.000 description 6
- 229910052718 tin Inorganic materials 0.000 description 6
- 239000003053 toxin Substances 0.000 description 6
- 231100000765 toxin Toxicity 0.000 description 6
- 108700012359 toxins Proteins 0.000 description 6
- JBRZTFJDHDCESZ-UHFFFAOYSA-N AsGa Chemical compound [As]#[Ga] JBRZTFJDHDCESZ-UHFFFAOYSA-N 0.000 description 5
- 229910001218 Gallium arsenide Inorganic materials 0.000 description 5
- 150000001412 amines Chemical class 0.000 description 5
- 150000001413 amino acids Chemical class 0.000 description 5
- 239000000427 antigen Substances 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- 230000003197 catalytic effect Effects 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 239000007789 gas Substances 0.000 description 5
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 5
- 229910052737 gold Inorganic materials 0.000 description 5
- 239000010931 gold Substances 0.000 description 5
- 230000003287 optical effect Effects 0.000 description 5
- 239000012071 phase Substances 0.000 description 5
- 229920001184 polypeptide Polymers 0.000 description 5
- 102000004196 processed proteins & peptides Human genes 0.000 description 5
- 239000000376 reactant Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 229910052717 sulfur Inorganic materials 0.000 description 5
- 125000003396 thiol group Chemical class [H]S* 0.000 description 5
- GPXJNWSHGFTCBW-UHFFFAOYSA-N Indium phosphide Chemical compound [In]#P GPXJNWSHGFTCBW-UHFFFAOYSA-N 0.000 description 4
- 206010028980 Neoplasm Diseases 0.000 description 4
- 229910052581 Si3N4 Inorganic materials 0.000 description 4
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 4
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 229910052782 aluminium Inorganic materials 0.000 description 4
- 108091007433 antigens Proteins 0.000 description 4
- 102000036639 antigens Human genes 0.000 description 4
- UHYPYGJEEGLRJD-UHFFFAOYSA-N cadmium(2+);selenium(2-) Chemical compound [Se-2].[Cd+2] UHYPYGJEEGLRJD-UHFFFAOYSA-N 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 239000002041 carbon nanotube Substances 0.000 description 4
- 229910021393 carbon nanotube Inorganic materials 0.000 description 4
- 239000004020 conductor Substances 0.000 description 4
- 230000007613 environmental effect Effects 0.000 description 4
- 230000005669 field effect Effects 0.000 description 4
- 229910052733 gallium Inorganic materials 0.000 description 4
- 229910021478 group 5 element Inorganic materials 0.000 description 4
- 239000005556 hormone Substances 0.000 description 4
- 229940088597 hormone Drugs 0.000 description 4
- 229910052738 indium Inorganic materials 0.000 description 4
- 150000002739 metals Chemical class 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 238000000059 patterning Methods 0.000 description 4
- 239000002356 single layer Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 239000012808 vapor phase Substances 0.000 description 4
- WYTZZXDRDKSJID-UHFFFAOYSA-N (3-aminopropyl)triethoxysilane Chemical group CCO[Si](OCC)(OCC)CCCN WYTZZXDRDKSJID-UHFFFAOYSA-N 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 3
- 108060003951 Immunoglobulin Proteins 0.000 description 3
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 3
- 108700005091 Immunoglobulin Genes Proteins 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000008151 electrolyte solution Substances 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 229910021480 group 4 element Inorganic materials 0.000 description 3
- 229910021476 group 6 element Inorganic materials 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 102000018358 immunoglobulin Human genes 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000001788 irregular Effects 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000000813 microcontact printing Methods 0.000 description 3
- 229910052759 nickel Inorganic materials 0.000 description 3
- 239000002777 nucleoside Substances 0.000 description 3
- 239000002773 nucleotide Substances 0.000 description 3
- 125000003729 nucleotide group Chemical group 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 239000010452 phosphate Substances 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 230000009870 specific binding Effects 0.000 description 3
- 230000035882 stress Effects 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000010409 thin film Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 102000014914 Carrier Proteins Human genes 0.000 description 2
- 102000000844 Cell Surface Receptors Human genes 0.000 description 2
- 108010001857 Cell Surface Receptors Proteins 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 2
- 229910002601 GaN Inorganic materials 0.000 description 2
- 102000003886 Glycoproteins Human genes 0.000 description 2
- 108090000288 Glycoproteins Proteins 0.000 description 2
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 2
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 2
- 229910000673 Indium arsenide Inorganic materials 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- DRTQHJPVMGBUCF-XVFCMESISA-N Uridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-XVFCMESISA-N 0.000 description 2
- 125000003172 aldehyde group Chemical group 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 229910052787 antimony Inorganic materials 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 229910052785 arsenic Inorganic materials 0.000 description 2
- 238000005452 bending Methods 0.000 description 2
- 239000012472 biological sample Substances 0.000 description 2
- 229910052793 cadmium Inorganic materials 0.000 description 2
- 238000004364 calculation method Methods 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000002800 charge carrier Substances 0.000 description 2
- 238000005229 chemical vapour deposition Methods 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000000151 deposition Methods 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 230000005595 deprotonation Effects 0.000 description 2
- 238000010537 deprotonation reaction Methods 0.000 description 2
- 238000009795 derivation Methods 0.000 description 2
- 229910003460 diamond Inorganic materials 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 239000000539 dimer Substances 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 238000007877 drug screening Methods 0.000 description 2
- 238000005530 etching Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000007306 functionalization reaction Methods 0.000 description 2
- 238000013537 high throughput screening Methods 0.000 description 2
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- FDGQSTZJBFJUBT-UHFFFAOYSA-N hypoxanthine Chemical compound O=C1NC=NC2=C1NC=N2 FDGQSTZJBFJUBT-UHFFFAOYSA-N 0.000 description 2
- 229940127121 immunoconjugate Drugs 0.000 description 2
- RPQDHPTXJYYUPQ-UHFFFAOYSA-N indium arsenide Chemical compound [In]#[As] RPQDHPTXJYYUPQ-UHFFFAOYSA-N 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 238000002032 lab-on-a-chip Methods 0.000 description 2
- 244000144972 livestock Species 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 230000005499 meniscus Effects 0.000 description 2
- 229910052753 mercury Inorganic materials 0.000 description 2
- 238000001053 micromoulding Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 239000002073 nanorod Substances 0.000 description 2
- 150000003833 nucleoside derivatives Chemical class 0.000 description 2
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical compound C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 2
- 238000002161 passivation Methods 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 238000004987 plasma desorption mass spectroscopy Methods 0.000 description 2
- 238000001020 plasma etching Methods 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000002331 protein detection Methods 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- SBIBMFFZSBJNJF-UHFFFAOYSA-N selenium;zinc Chemical compound [Se]=[Zn] SBIBMFFZSBJNJF-UHFFFAOYSA-N 0.000 description 2
- 239000013545 self-assembled monolayer Substances 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- PORWMNRCUJJQNO-UHFFFAOYSA-N tellurium atom Chemical compound [Te] PORWMNRCUJJQNO-UHFFFAOYSA-N 0.000 description 2
- 229910052716 thallium Inorganic materials 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 229910052723 transition metal Inorganic materials 0.000 description 2
- 150000003624 transition metals Chemical class 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 238000009834 vaporization Methods 0.000 description 2
- 230000008016 vaporization Effects 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- YBNMDCCMCLUHBL-UHFFFAOYSA-N (2,5-dioxopyrrolidin-1-yl) 4-pyren-1-ylbutanoate Chemical compound C=1C=C(C2=C34)C=CC3=CC=CC4=CC=C2C=1CCCC(=O)ON1C(=O)CCC1=O YBNMDCCMCLUHBL-UHFFFAOYSA-N 0.000 description 1
- RIFDKYBNWNPCQK-IOSLPCCCSA-N (2r,3s,4r,5r)-2-(hydroxymethyl)-5-(6-imino-3-methylpurin-9-yl)oxolane-3,4-diol Chemical compound C1=2N(C)C=NC(=N)C=2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O RIFDKYBNWNPCQK-IOSLPCCCSA-N 0.000 description 1
- RKSLVDIXBGWPIS-UAKXSSHOSA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-iodopyrimidine-2,4-dione Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 RKSLVDIXBGWPIS-UAKXSSHOSA-N 0.000 description 1
- QLOCVMVCRJOTTM-TURQNECASA-N 1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-prop-1-ynylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C#CC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 QLOCVMVCRJOTTM-TURQNECASA-N 0.000 description 1
- PISWNSOQFZRVJK-XLPZGREQSA-N 1-[(2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-2-sulfanylidenepyrimidin-4-one Chemical compound S=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 PISWNSOQFZRVJK-XLPZGREQSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-UHFFFAOYSA-N 1-beta-D-Xylofuranosyl-NH-Cytosine Natural products O=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 UHDGCWIWMRVCDJ-UHFFFAOYSA-N 0.000 description 1
- YKBGVTZYEHREMT-KVQBGUIXSA-N 2'-deoxyguanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](CO)O1 YKBGVTZYEHREMT-KVQBGUIXSA-N 0.000 description 1
- CKTSBUTUHBMZGZ-SHYZEUOFSA-N 2'‐deoxycytidine Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 CKTSBUTUHBMZGZ-SHYZEUOFSA-N 0.000 description 1
- ZDTFMPXQUSBYRL-UUOKFMHZSA-N 2-Aminoadenosine Chemical compound C12=NC(N)=NC(N)=C2N=CN1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O ZDTFMPXQUSBYRL-UUOKFMHZSA-N 0.000 description 1
- JRYMOPZHXMVHTA-DAGMQNCNSA-N 2-amino-7-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1h-pyrrolo[2,3-d]pyrimidin-4-one Chemical compound C1=CC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O JRYMOPZHXMVHTA-DAGMQNCNSA-N 0.000 description 1
- MWBWWFOAEOYUST-UHFFFAOYSA-N 2-aminopurine Chemical compound NC1=NC=C2N=CNC2=N1 MWBWWFOAEOYUST-UHFFFAOYSA-N 0.000 description 1
- RHFUOMFWUGWKKO-XVFCMESISA-N 2-thiocytidine Chemical compound S=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 RHFUOMFWUGWKKO-XVFCMESISA-N 0.000 description 1
- XXSIICQLPUAUDF-TURQNECASA-N 4-amino-1-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-prop-1-ynylpyrimidin-2-one Chemical compound O=C1N=C(N)C(C#CC)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 XXSIICQLPUAUDF-TURQNECASA-N 0.000 description 1
- AGFIRQJZCNVMCW-UAKXSSHOSA-N 5-bromouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(Br)=C1 AGFIRQJZCNVMCW-UAKXSSHOSA-N 0.000 description 1
- FHIDNBAQOFJWCA-UAKXSSHOSA-N 5-fluorouridine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(F)=C1 FHIDNBAQOFJWCA-UAKXSSHOSA-N 0.000 description 1
- ZAYHVCMSTBRABG-JXOAFFINSA-N 5-methylcytidine Chemical compound O=C1N=C(N)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 ZAYHVCMSTBRABG-JXOAFFINSA-N 0.000 description 1
- KDOPAZIWBAHVJB-UHFFFAOYSA-N 5h-pyrrolo[3,2-d]pyrimidine Chemical compound C1=NC=C2NC=CC2=N1 KDOPAZIWBAHVJB-UHFFFAOYSA-N 0.000 description 1
- UEHOMUNTZPIBIL-UUOKFMHZSA-N 6-amino-9-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-7h-purin-8-one Chemical compound O=C1NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O UEHOMUNTZPIBIL-UUOKFMHZSA-N 0.000 description 1
- RYYIULNRIVUMTQ-UHFFFAOYSA-N 6-chloroguanine Chemical compound NC1=NC(Cl)=C2N=CNC2=N1 RYYIULNRIVUMTQ-UHFFFAOYSA-N 0.000 description 1
- HCAJQHYUCKICQH-VPENINKCSA-N 8-Oxo-7,8-dihydro-2'-deoxyguanosine Chemical compound C1=2NC(N)=NC(=O)C=2NC(=O)N1[C@H]1C[C@H](O)[C@@H](CO)O1 HCAJQHYUCKICQH-VPENINKCSA-N 0.000 description 1
- MSSXOMSJDRHRMC-UHFFFAOYSA-N 9H-purine-2,6-diamine Chemical compound NC1=NC(N)=C2NC=NC2=N1 MSSXOMSJDRHRMC-UHFFFAOYSA-N 0.000 description 1
- HDZZVAMISRMYHH-UHFFFAOYSA-N 9beta-Ribofuranosyl-7-deazaadenin Natural products C1=CC=2C(N)=NC=NC=2N1C1OC(CO)C(O)C1O HDZZVAMISRMYHH-UHFFFAOYSA-N 0.000 description 1
- 229910002704 AlGaN Inorganic materials 0.000 description 1
- 229910017115 AlSb Inorganic materials 0.000 description 1
- 229910000980 Aluminium gallium arsenide Inorganic materials 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 229910015849 BeSiN2 Inorganic materials 0.000 description 1
- 229910015894 BeTe Inorganic materials 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 108010078791 Carrier Proteins Proteins 0.000 description 1
- 229910004608 CdSnAs2 Inorganic materials 0.000 description 1
- 229910004613 CdTe Inorganic materials 0.000 description 1
- 108020004635 Complementary DNA Proteins 0.000 description 1
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 1
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 1
- 229910021593 Copper(I) fluoride Inorganic materials 0.000 description 1
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 1
- 241000557626 Corvus corax Species 0.000 description 1
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical compound [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 description 1
- 229910016518 CuGeP3 Inorganic materials 0.000 description 1
- 229910016351 CuSi2P3 Inorganic materials 0.000 description 1
- UHDGCWIWMRVCDJ-PSQAKQOGSA-N Cytidine Natural products O=C1N=C(N)C=CN1[C@@H]1[C@@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-PSQAKQOGSA-N 0.000 description 1
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 1
- CKTSBUTUHBMZGZ-UHFFFAOYSA-N Deoxycytidine Natural products O=C1N=C(N)C=CN1C1OC(CO)C(O)C1 CKTSBUTUHBMZGZ-UHFFFAOYSA-N 0.000 description 1
- 101000617550 Dictyostelium discoideum Presenilin-A Proteins 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229910005540 GaP Inorganic materials 0.000 description 1
- 229910005542 GaSb Inorganic materials 0.000 description 1
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
- JMASRVWKEDWRBT-UHFFFAOYSA-N Gallium nitride Chemical compound [Ga]#N JMASRVWKEDWRBT-UHFFFAOYSA-N 0.000 description 1
- 229910005987 Ge3N4 Inorganic materials 0.000 description 1
- 229910005829 GeS Inorganic materials 0.000 description 1
- 229910005866 GeSe Inorganic materials 0.000 description 1
- 229910005900 GeTe Inorganic materials 0.000 description 1
- 229910004262 HgTe Inorganic materials 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- UGQMRVRMYYASKQ-UHFFFAOYSA-N Hypoxanthine nucleoside Natural products OC1C(O)C(CO)OC1N1C(NC=NC2=O)=C2N=C1 UGQMRVRMYYASKQ-UHFFFAOYSA-N 0.000 description 1
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 1
- 229930010555 Inosine Natural products 0.000 description 1
- UGQMRVRMYYASKQ-KQYNXXCUSA-N Inosine Chemical compound O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1C2=NC=NC(O)=C2N=C1 UGQMRVRMYYASKQ-KQYNXXCUSA-N 0.000 description 1
- 108090001090 Lectins Proteins 0.000 description 1
- 102000004856 Lectins Human genes 0.000 description 1
- 229910002665 PbTe Inorganic materials 0.000 description 1
- 102000057297 Pepsin A Human genes 0.000 description 1
- 108090000284 Pepsin A Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108091093037 Peptide nucleic acid Proteins 0.000 description 1
- 239000005922 Phosphane Substances 0.000 description 1
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 229910008051 Si-OH Inorganic materials 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- 229910021608 Silver(I) fluoride Inorganic materials 0.000 description 1
- 229910006358 Si—OH Inorganic materials 0.000 description 1
- 229910005642 SnTe Inorganic materials 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-N Thiophosphoric acid Chemical class OP(O)(S)=O RYYWUUFWQRZTIU-UHFFFAOYSA-N 0.000 description 1
- 102000018265 Virus Receptors Human genes 0.000 description 1
- 108010066342 Virus Receptors Proteins 0.000 description 1
- 229910007475 ZnGeP2 Inorganic materials 0.000 description 1
- 229910007707 ZnSnSb2 Inorganic materials 0.000 description 1
- 229910007709 ZnTe Inorganic materials 0.000 description 1
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- PPQRONHOSHZGFQ-LMVFSUKVSA-N aldehydo-D-ribose 5-phosphate Chemical group OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PPQRONHOSHZGFQ-LMVFSUKVSA-N 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 238000000137 annealing Methods 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- DRTQHJPVMGBUCF-PSQAKQOGSA-N beta-L-uridine Natural products O[C@H]1[C@@H](O)[C@H](CO)O[C@@H]1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-PSQAKQOGSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000008364 bulk solution Substances 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000013522 chelant Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 1
- 229910052593 corundum Inorganic materials 0.000 description 1
- DMSZORWOGDLWGN-UHFFFAOYSA-N ctk1a3526 Chemical compound NP(N)(N)=O DMSZORWOGDLWGN-UHFFFAOYSA-N 0.000 description 1
- UHDGCWIWMRVCDJ-ZAKLUEHWSA-N cytidine Chemical compound O=C1N=C(N)C=CN1[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O1 UHDGCWIWMRVCDJ-ZAKLUEHWSA-N 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229920000359 diblock copolymer Polymers 0.000 description 1
- NAGJZTKCGNOGPW-UHFFFAOYSA-K dioxido-sulfanylidene-sulfido-$l^{5}-phosphane Chemical compound [O-]P([O-])([S-])=S NAGJZTKCGNOGPW-UHFFFAOYSA-K 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 238000007876 drug discovery Methods 0.000 description 1
- 238000003255 drug test Methods 0.000 description 1
- 239000012636 effector Substances 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000010291 electrical method Methods 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 238000000609 electron-beam lithography Methods 0.000 description 1
- 238000005421 electrostatic potential Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 229910021389 graphene Inorganic materials 0.000 description 1
- 229910021474 group 7 element Inorganic materials 0.000 description 1
- 229940029575 guanosine Drugs 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 238000004050 hot filament vapor deposition Methods 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical group 0.000 description 1
- 230000003100 immobilizing effect Effects 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- WPYVAWXEWQSOGY-UHFFFAOYSA-N indium antimonide Chemical compound [Sb]#[In] WPYVAWXEWQSOGY-UHFFFAOYSA-N 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 150000002484 inorganic compounds Chemical class 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 229960003786 inosine Drugs 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000009413 insulation Methods 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 229910052745 lead Inorganic materials 0.000 description 1
- 239000002523 lectin Substances 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 210000001165 lymph node Anatomy 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 238000011326 mechanical measurement Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 239000002082 metal nanoparticle Substances 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 238000004377 microelectronic Methods 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 238000002324 minimally invasive surgery Methods 0.000 description 1
- 238000005442 molecular electronic Methods 0.000 description 1
- 230000008450 motivation Effects 0.000 description 1
- 239000002048 multi walled nanotube Substances 0.000 description 1
- 239000002159 nanocrystal Substances 0.000 description 1
- 238000013188 needle biopsy Methods 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 229910052755 nonmetal Inorganic materials 0.000 description 1
- 238000001668 nucleic acid synthesis Methods 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000005693 optoelectronics Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 210000002741 palatine tonsil Anatomy 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229940111202 pepsin Drugs 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 238000002823 phage display Methods 0.000 description 1
- 229910000064 phosphane Inorganic materials 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 238000005268 plasma chemical vapour deposition Methods 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229910052699 polonium Inorganic materials 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229910021426 porous silicon Inorganic materials 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000007639 printing Methods 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 230000005588 protonation Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 150000003290 ribose derivatives Chemical group 0.000 description 1
- RHFUOMFWUGWKKO-UHFFFAOYSA-N s2C Natural products S=C1N=C(N)C=CN1C1C(O)C(O)C(CO)O1 RHFUOMFWUGWKKO-UHFFFAOYSA-N 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000000682 scanning probe acoustic microscopy Methods 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- SCPYDCQAZCOKTP-UHFFFAOYSA-N silanol Chemical compound [SiH3]O SCPYDCQAZCOKTP-UHFFFAOYSA-N 0.000 description 1
- 125000005372 silanol group Chemical group 0.000 description 1
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- REYHXKZHIMGNSE-UHFFFAOYSA-M silver monofluoride Chemical compound [F-].[Ag+] REYHXKZHIMGNSE-UHFFFAOYSA-M 0.000 description 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 description 1
- MBEGFNBBAVRKLK-UHFFFAOYSA-N sodium;iminomethylideneazanide Chemical compound [Na+].[NH-]C#N MBEGFNBBAVRKLK-UHFFFAOYSA-N 0.000 description 1
- 238000002174 soft lithography Methods 0.000 description 1
- 239000006104 solid solution Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- OCGWQDWYSQAFTO-UHFFFAOYSA-N tellanylidenelead Chemical compound [Pb]=[Te] OCGWQDWYSQAFTO-UHFFFAOYSA-N 0.000 description 1
- RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical compound [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- HQYALQRYBUJWDH-UHFFFAOYSA-N trimethoxy(propyl)silane Chemical compound CCC[Si](OC)(OC)OC HQYALQRYBUJWDH-UHFFFAOYSA-N 0.000 description 1
- QLNOVKKVHFRGMA-UHFFFAOYSA-N trimethoxy(propyl)silane Chemical group [CH2]CC[Si](OC)(OC)OC QLNOVKKVHFRGMA-UHFFFAOYSA-N 0.000 description 1
- HDZZVAMISRMYHH-KCGFPETGSA-N tubercidin Chemical compound C1=CC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O HDZZVAMISRMYHH-KCGFPETGSA-N 0.000 description 1
- 239000000439 tumor marker Substances 0.000 description 1
- 230000005641 tunneling Effects 0.000 description 1
- DRTQHJPVMGBUCF-UHFFFAOYSA-N uracil arabinoside Natural products OC1C(O)C(CO)OC1N1C(=O)NC(=O)C=C1 DRTQHJPVMGBUCF-UHFFFAOYSA-N 0.000 description 1
- 229940045145 uridine Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000007740 vapor deposition Methods 0.000 description 1
- 238000001947 vapour-phase growth Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 229910001845 yogo sapphire Inorganic materials 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
- G01N33/552—Glass or silica
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y15/00—Nanotechnology for interacting, sensing or actuating, e.g. quantum dots as markers in protein assays or molecular motors
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y30/00—Nanotechnology for materials or surface science, e.g. nanocomposites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/403—Cells and electrode assemblies
- G01N27/414—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS
- G01N27/4146—Ion-sensitive or chemical field-effect transistors, i.e. ISFETS or CHEMFETS involving nanosized elements, e.g. nanotubes, nanowires
Definitions
- Various aspects of the present invention generally relate to nanoscale wire devices and methods for use in determining analytes suspected to be present in a sample.
- Nanoscopic articles might be well-suited for transport of charge carriers and excitons (e.g. electrons, electron pairs, etc.) and thus may be useful as building blocks in nanoscale electronics applications.
- Nanowires are well-suited for efficient transport of charge carriers and excitons, and thus are expected to be important building blocks for nanoscale electronics and optoelectronics.
- Nanoscale wires having selectively functionalized surfaces have been described in U.S. Patent Application Serial No. 10/020,004, entitled “Nanosensors,” filed
- Nanoscale wire sensors have also been described in U.S. Patent Application Serial No. 11/501,466, entitled “Nanoscale Sensors,” filed August 9, 2006, also incorporated herein by reference.
- functionalization of the nanoscale wire may permit interaction of the functionalized nanoscale wire with various entities, such as molecular entities, and the interaction induces a change in a property of the functionalized nanowire, which provides a mechanism for a nanoscale sensor device for detecting the presence or absence of an analyte suspected to be present in a sample.
- Various aspects of the present invention generally relate to nanoscale wire devices and methods for use in determining analytes suspected to be present in a sample.
- the subject matter of the present invention involves, in some cases, interrelated products, alternative solutions to a particular problem, and/or a plurality of different uses of one or more systems and/or articles.
- the invention is directed to a method.
- the methods includes an act of exposing a nanoscale wire, having a reaction entity immobilized relative thereto, to a solution suspected of containing an analyte that the reaction entity is able to bind.
- the nanoscale wire has a Debye screening length, when the nanoscale wire is placed in the solution, that is greater than the average cross-sectional dimension of the nanoscale wire.
- the method also includes an act of operating the nanoscale wire under conditions wherein the nanoscale wire has a conductance that is not linearly proportional to voltage applied to voltage applied to the nanoscale wire.
- the method in another set of embodiments, includes acts of causing an analyte to bind to a nanoscale wire having a reaction entity immobilized relative thereto, and determining a change in charge of the analyte of less than about 10 "17 C.
- the invention is directed to an article in another aspect.
- the article includes a nanoscale wire, having a reaction entity immobilized relative thereto, where the nanoscale wire is exposed to a solution, such that the nanoscale wire has a Debye screening length in the solution that is greater than the average cross-sectional dimension of the nanoscale wire.
- the article includes a nanoscale wire, having a reaction entity immobilized relative thereto, where the nanoscale wire can determine a change in charge of an analyte of less than about 10 "17 C.
- the present invention is directed to a method of making one or more of the embodiments described herein, for example, a sensing device comprising a nanoscale wire.
- the present invention is directed to a method of using one or more of the embodiments described herein, for example, a sensing device comprising a nanoscale wire.
- Fig. 1 shows the screening effect of a nanoscale wire used as a sensor, in one embodiment of the invention
- Figs. 2A-2D illustrates pH sensing, according to another embodiment of the invention
- Figs. 3A-3D illustrates sensing of PSA/antibody conjugates, in yet another embodiment of the invention
- Figs. 4A-4F illustrate sensing of PSA/antibody conjugates, in still another embodiment of the invention.
- Fig. 5 shows the potential distribution of a nanoscale wire, according to yet another embodiment of the invention.
- Various aspects of the present invention generally relate to nanoscale wire devices and methods for use in determining analytes suspected to be present in a sample.
- One aspect of the invention provides a nanoscale wire that has improved sensitivity, for example, as the carrier concentration in the wire is controlled by an external gate voltage, and in some embodiments, the nanoscale wire can be used to determine a change in charge of less than about 10 " 7 C.
- the nanoscale wire in some cases, may be part of a field effect transistor (FET).
- FET field effect transistor
- the nanoscale wire has a Debye screening length that is greater than the average cross-sectional dimension of the nanoscale wire when the nanoscale wire is exposed to a solution suspected of containing an analyte.
- the Debye screening length associated with the carriers inside nanoscale wire may be adjusted by adjusting the voltage, for example, a gate voltage applied to an FET structure.
- the nanoscale wire can be operated
- aspects of the invention include assays, sensors, kits, and/or other devices that include such nanoscale wires, methods of making and/or using functionalized nanoscale wires (for example, in drug screening or high-throughput screening), and the like.
- various aspects of the present invention provide a sensing element comprising a nanoscale wire able to interact with one or more analytes.
- the nanoscale wire may be used to determine an analyte as part of an assay for determining or diagnosing cancer or other medical conditions (e.g., by determining a suitable marker, for example, a hormone, an enzyme, a peptide, a virus, etc., and diagnosing the cancer or other medical condition based on the determination of the marker), for determining drugs (e.g., as part of a drug assay or a drug screen, for instance, to identify a drug able to treat a medical condition such as cancer or aging), for determining toxins or other environmental agents (e.g., by determining binding of the toxin to a receptor), or the like.
- a suitable marker for example, a hormone, an enzyme, a peptide, a virus, etc.
- drugs e.g., as part of a drug assay or a drug screen, for instance, to identify a drug able to treat a medical condition such as cancer or aging
- determining toxins or other environmental agents e.g
- the invention is generally described herein in reference to a nanoscale wire, it should be understood that the invention is not limited to nanoscale wires.
- Many of the methods described herein can be applied to any nanomaterials or nanostructures whose properties are affected by the binding of analyte molecules on the surface.
- the methods of the present invention may be applied to a FET sensor device comprising nanoparticles that an analyte is able to bind.
- a nanoparticle (or other nanostructure) may be exposed to a solution such that the nanoparticle has a Debye screening length, when the nanoparticle is placed in the solution, that is greater than the average cross-sectional dimension of the nanoparticle or other nanostructure, or the sensor may be operated under conditions in which the nanoparticle (or other nanostructure) has a conductance that is not linearly proportional to voltage applied to voltage applied to the nanoparticle or other nanostructure.
- the nanoscale wire may have a reaction entity able to interact with an analyte of interest.
- Nanoscale sensing elements of the invention may be used, for example, to determine pH or metal ions, viruses, proteins or enzymes, nucleic acids (e.g. DNA, RNA, PNA, etc.), drugs, sugars, carbohydrates, a toxin (e.g., a harmful chemical, such as a chemical produced by a living organism that is harmful to other organisms), small molecules (e.g., having molecular weights of less than about 2000 Da, less than about 1500 Da, or less than about 1000 Da), or other analytes of interest, as further described herein.
- the analyte may be charged, or uncharged in some embodiments.
- single entities may be determined, for example, a single virus, a single protein, a single enzyme, a single nucleic acid molecule, a single drug molecule, a single carbohydrate molecule, etc.
- the sensing element includes a detector constructed and arranged to determine a change in a property of the nanoscale wire, for example, a change in light emission, a change in stress or shape, or a change in an electrical property of the nanoscale wire, such as voltage, current, conductivity, resistivity, inductance, impedance, electrical change, an electromagnetic change, etc.
- the nanoscale wire is addressable by a sample (e.g., a gas or liquid sample) containing, or at least suspected of containing, the analyte.
- a sample e.g., a gas or liquid sample
- the term "addressable,” e.g., by a fluid, is defined as the ability of the fluid to be positioned relative to the nanoscale wire so that the analytes suspected of being in the fluid are able to interact with the nanoscale wire.
- the fluid may be proximate to or in contact with the nanoscale wire.
- the fluid may be directed to the nanoscale wire through the use of a microfluidic channel, as further described below.
- reaction entity refers to any entity that can interact with an analyte in such a manner as to cause a detectable change in a property of a nanoscale wire.
- the reaction entity may comprise a binding partner to which the analyte binds.
- the reaction entity when a binding partner, can comprise a specific binding partner of the analyte.
- the reaction entity can form a coating on the nanoscale wire.
- Non-limiting examples of reaction entities include a nucleic acid (e.g., DNA or RNA), an antibody, a sugar or a carbohydrate, a protein or an enzyme, a ganglioside or a surfactant, etc., e.g., as discussed herein.
- a reaction entity associated with the nanoscale wire is able to interact with an analyte.
- the reaction entity as “associated” with or “immobilized” relative to the nanoscale wire, may be positioned in relation to the nanoscale wire (e.g., in close proximity or in contact) such that the analyte can be determined by determining a change in a characteristic or property of the nanoscale wire. Interaction of the analyte with the reaction entity may cause a detectable change or modulation in a property of the nanoscale wire, for example, through electrical coupling with the reaction entity.
- electrically coupled when used with reference to a nanoscale wire and an analyte, or other moiety such as a reaction entity, refers to an association between any of the analyte, other moiety, and the nanoscale wire such that electrons can move from one to the other, or in which a change in an electrical characteristic of one can be determined by the other. This can include electron flow between these entities, or a change in a state of charge, oxidation, or the like, that can be determined by the nanoscale wire.
- electrical coupling or immobilization can include direct covalent linkage between the analyte or other moiety and the nanoscale wire, indirect covalent coupling (for instance, via a linker, and/or a plurality of linkers, e.g., serially), direct or indirect ionic bonding between the analyte (or other moiety) and the nanoscale wire, direct or indirect bonding of both the analyte and the nanoscale wire to a particle (i.e., the particle acts as a linker between the analyte and the nanoscale wire), direct or indirect bonding of both the analyte and the nanoscale wire to a common surface (i.e., the surface acts as a linker), or other types of bonding or interactions (e.g.
- the reaction entity may be positioned relative to the nanoscale wire to cause a detectable change in the nanoscale wire.
- the reaction entity may be positioned within about 100 ran of the nanoscale wire, within about 75 nm of the nanoscale wire, within about 50 nm of the nanoscale wire, within about 20 run of the nanoscale wire, within about 15 nm of the nanoscale wire, or within about 10 nm of the nanoscale wire.
- the actual proximity can be determined by those of ordinary skill in the art.
- the reaction entity is positioned less than about 5 nm from the nanoscale wire. In other cases, the reaction entity is positioned within about 4 nm, within about 3 nm, within about 2 nm, or within about 1 nm of the nanoscale wire.
- the reaction entity is fastened to or directly bonded (e.g., covalently) to the nanoscale wire, e.g., as further described herein.
- the reaction entity is not directly bonded to the nanoscale wire, but is otherwise immobilized relative to the nanoscale wire, i.e., the reaction entity is indirectly immobilized relative to the nanoscale wire.
- the reaction entity may be attached to the nanoscale wire through a linker, i.e., a species (or plurality of species) to which the reaction entity and the nanoscale wire are each immobilized relative thereto, e.g., covalently or non-covalently bound to.
- a linker may be directly bonded to the nanoscale wire, and the reaction entity may be directly bonded to the linker, or the reaction entity may not be directly bonded to the linker, but immobilized relative to the linker, e.g., through the use of non-covalent bonds such as hydrogen bonding (e.g., as in complementary nucleic acid-nucleic acid interactions), hydrophobic interactions (e.g., between hydrocarbon chains), entropic interactions, or the like.
- the linker may or may not be directly bonded (e.g., covalently) to the nanoscale wire.
- the sensitivity of the reaction entity to the analyte may be enhanced by selecting conditions in which the Debye screening length of the nanoscale wire is controlled such that the Debye screening length is greater than the average cross-sectional dimension of the nanoscale wire when the nanoscale wire is exposed to a solution suspected of containing the analyte.
- the Debye screening length can be measured by those of ordinary skill in the art (see, e.g., the examples), and varies as a function of various properties of both the nanoscale wire (e.g., the doping level and/or the dielectric constant) and the environment in which the nanoscale wire is located (e.g., the temperature of the solution).
- the Debye length of the nanoscale wire in some embodiments, can be determined as:
- ⁇ is the electric constant of wire material,/? is the carrier concentration in the nanowire
- k ⁇ is the Boltzmann constant (sometimes also k)
- T is the temperature
- e is the elementary charge.
- the Debye length of nanoscale wire can be adjusted in some cases by controlling the voltage of the nanoscale wire, e.g., in the gate of a FET comprising the nanoscale wire, which may change the carrier concentration inside wire.
- the Debye length may be controlled to be longer than the cross- sectional dimension of the nanoscale wire.
- the Debye screening length (more formally, the Debye-
- ⁇ 0 is the permittivity of free space
- ⁇ r is the dielectric constant of the solution
- k is the Boltzmann constant
- T is the temperature
- N A is Avogadro's Number
- e is the elementary charge.
- suitable environmental conditions e.g., temperature and/or ionic strength of a given solution
- the screening length may be greater than the average cross-sectional dimension of the nanoscale wire.
- the ionic strength of a solution may be controlled by controlling the concentration of phosphate and/or other ions (e.g., K + , Cl " , etc.) within the solution.
- the sensitivity of the reaction entity to the analyte may be enhanced by operating the nanoscale wire under conditions wherein the nanoscale wire has a conductance that is not linearly proportional to voltage applied to voltage applied to the nanoscale wire, i.e., within the "subthreshold regime.”
- the conductance will depend substantially exponentially on the voltage applied to the nanoscale wire, e.g., the electrolyte gate voltage if the nanoscale wire is part of an FET.
- the nanoscale wire can be used to determine a change in charge of an analyte of less than about 10 "17 C, and in some cases, less than about 5x10 "18 C, less than about 3x 10 "18 C, less than about 10 "18 C, or less than about 5x10 "19 C.
- the present invention generally relates to the attachment of reaction entities, such as biological entities, to the surfaces of nanoscale wires, in some cases by using covalent bonding.
- entity is thus immobilized with respect to the surface of the nanoscale wire.
- a linker is used to covalently immobilize the entity with respect to the nanoscale wire.
- the entity may be covalently immobilized with respect to the surface of the nanoscale wire at relatively short distances, depending on the size of the linker and/or the precursors thereof.
- the entity may be immobilized at a distance of less than about 20 nm, less than about 15 nm, less than about 10 nm, less than about 9 nm, less than about 8 nm, less than about 7 nm, less than about 6 nm, less than about 5 nm, less than about 4 nm, less than about 3 nm, less than about 2 nm, or less than about 1 nm from the surface of the nanoscale wire.
- the proximity of the entity may control or otherwise affect electronic and/or other properties of the nanoscale wire, for example, the conductivity of the nanoscale wire.
- Non-limiting examples of chemistries suitable for attaching entities to surfaces of nanoscale wires, optionally via one or more linkers include the following.
- the surface of the nanoscale wire may be functionalized, for example, the surface may be functionalized with aldehydes, amines, thiols, or the like, which may form nitrogen-containing or sulfur-containing covalent bonds.
- the reaction entity may be covalently bound to the nanoscale wire through the use of a moiety such as an aldehyde moiety, an amine moiety, and/or a thiol moiety.
- a nanoscale wire may be reacted with an aldehyde, amine, or a thiol in solution to functionalize the nanoscale wire with the appropriate moiety, e.g., such that the surface of the nanoscale wire includes terminal aldehyde, amine, and/or thiol groups. Additional examples are disclosed in U.S. Patent Application Serial No. 11/501,466, filed August 9, 2006, entitled “Nanoscale Sensors," by Lieber, et al. , incorporated herein by reference.
- One or more entities e.g., reaction entities such as proteins, enzymes, nucleic acids, antibodies, receptors, ligands, etc.
- reaction entities such as proteins, enzymes, nucleic acids, antibodies, receptors, ligands, etc.
- the surface of the nanoscale wire is then passivated, e.g., blocked with one or more compounds that causes the moieties to become unreactive.
- passivating agents include ethanolamine.
- a solution may be added to the nanowires that includes one or more passivating agents.
- a sensing element comprising a nanoscale wire and a detector constructed and arranged to determine a property and/or a change in a property of the nanoscale wire.
- alteration of a property of the nanoscale wire may be indicative of an interaction between a reaction entity and an analyte (e.g., association or dissociation of the reaction entity and the analyte).
- analyte e.g., association or dissociation of the reaction entity and the analyte
- any detector capable of determining a property associated with the nanoscale wire can be used.
- the property can be electronic, electromagnetic, optical, mechanical, or the like.
- Examples of electrical or magnetic properties that can be determined include, but are not limited to, voltage, current, conductivity, resistance, impedance, inductance, charge, etc.
- Examples of optical properties associated with the nanoscale wire include its emission intensity and/or emission wavelength, e.g. where the nanoscale wire is emissive.
- the detector will include a power source and a metering device, for example a voltmeter or an ammeter.
- a conductance (or a change in conductance) less than about 1 nS in a nanoscale wire sensor of the invention can be detected.
- a conductance in the range of thousandths of a nS can be detected.
- conductances of less than about 10 microsiemens, less than about 1 microsiemen, less than about 100 nS, or less than about 10 nS can be detected.
- concentration of a species, or analyte may be detected from femtomolar concentrations, to nanomolar, micromolar, millimolar, and to molar concentrations and above.
- a charged analyte may be determined by determining a change in an electrical property of the nanoscale wire, for example, conductivity. Immobilizing a charged analyte relative to the nanoscale wire may cause a change in the conductivity of the nanoscale wire, and in some cases, the distance between the charged analyte and the nanoscale wire may determine the magnitude of the change in conductivity of the nanoscale wire. Uncharged analytes can be similarly determined, for instance, by causing the analyte to become charged, e.g., by altering environmental conditions such as pH (by raising or lowering pH), temperature, reactants, or the like, by reacting the analyte with a charged moiety, or the like.
- sample refers to any cell, lysate, tissue, or fluid from a biological source (a "biological sample"), or any other medium, biological or non-biological, that can be evaluated in accordance with the invention.
- sample may be, for instance, a liquid (e.g., a solution or a suspension) or a gas.
- a sample includes, but is not limited to, a biological sample drawn from an organism (e.g.
- a human a non-human mammal, an invertebrate, a plant, a fungus, an algae, a bacteria, a virus, etc.
- a sample drawn from food designed for human consumption a sample including food designed for animal consumption such as livestock feed, milk, an organ donation sample, a sample of blood destined for a blood supply, a sample from a water supply, a soil sample, or the like.
- the sample may be a sample suspected of containing an analyte.
- a “sample suspected of containing” a particular component means a sample with respect to which the content of the component is unknown.
- a fluid sample from a human suspected of having a disease, but not known to have the disease defines a sample suspected of containing the disease.
- Sample in this context includes naturally- occurring samples, such as physiological samples from humans or other animals, samples from food, livestock feed, water, soil, etc. Typical samples include tissue biopsies, cells, cell lysates, whole blood, serum or other blood fractions, urine, ocular fluid, saliva, fluid or other samples from tonsils, lymph nodes, needle biopsies, etc.
- sample sizes for exposure of a sample to a nanoscale sensor of the invention, can be used in various embodiments.
- the sample size used in nanoscale sensors may be less than or equal to about 10 microliters, less than or equal to about 1 microliter, or less than or equal to about 0.1 microliter.
- the sample size may be as small as about 10 nanoliters, 1 nanoliter, or less, in certain instances.
- the nanoscale sensor also allows for unique accessibility to biological species and may be used for in vivo and/or in vitro applications. When used in vivo, in some case, the nanoscale sensor and corresponding method result in a minimally invasive procedure.
- the invention in some embodiments, involves a sensing element comprising a sample exposure region and a nanoscale wire able to detect the presence or absence of an analyte, and/or the concentration of the analyte.
- the "sample exposure region” may be any region in close proximity to the nanoscale wire where a sample in the sample exposure region addresses at least a portion of the nanoscale wire. Examples of sample exposure regions include, but are not limited to, a well, a channel, a microfluidic channel, or a gel.
- the sample exposure region is able to hold a sample proximate the nanoscale wire, and/or may direct a sample toward the nanoscale wire for determination of an analyte in the sample.
- the nanoscale wire may be positioned adjacent or within the sample exposure region.
- the nanoscale wire may be a probe that is inserted into a fluid or fluid flow path.
- the nanoscale wire probe may also comprise, in some instances, a microneedle that supports and/or is integral with the nanoscale wire, and the sample exposure region may be addressable by the microneedle.
- a device that is constructed and arranged for insertion of a microneedle probe into a sample can include a region surrounding or otherwise in contact with the microneedle that defines the sample exposure region, and a sample in the sample exposure region is addressable by the nanoscale wire, and vice versa.
- Fluid flow channels can be created at a size and scale advantageous for use in the invention (microchannels) using a variety of techniques such as those described in International Patent Application Serial No. PCT/US97/04005, entitled “Method of Forming Articles and Patterning Surfaces via Capillary Micromolding,” filed March 14, 1997, published as Publication No. WO 97/33737 on September 18, 1997, and incorporated herein by reference.
- a sample such as a fluid suspected of containing an analyte that is to be determined, may be presented to a sample exposure region of a sensing element comprising a nanoscale wire.
- An analyte present in the fluid that is able to bind to the nanoscale wire and/or a reaction entity immobilized relative to the nanoscale wire may cause a change in a property of the nanoscale wire that is determinable upon binding, e.g. using conventional electronics. If the analyte is not present in the fluid, the relevant property of the nanoscale wire will remain unchanged, and the detector will measure no significant change. Thus, according to this particular example, the presence or absence of an analyte can be determined by monitoring changes, or lack thereof, in the property of the nanoscale wire.
- the magnitude of the change may be a function of the concentration of the analyte, and/or a function of some other relevant property of the analyte (e.g., charge or size, etc.).
- some other relevant property of the analyte e.g., charge or size, etc.
- one or more nanoscale wires may be positioned in a channel or in a microfluidic channel, which may define the sample exposure region in some cases.
- a "channel" is a conduit that is able to transport one or more fluids specifically from one location to another. Materials may flow through the channels, continuously, randomly, intermittently, etc.
- the channel may be a closed channel, or a channel that is open, for example, open to the external environment.
- the channel can include characteristics that facilitate control over fluid transport, e.g., structural characteristics, physical/chemical characteristics (e.g., hydrophobicity vs. hydrophilicity) and/or other characteristics that can exert a force (e.g., a containing force) on a fluid when within the channel.
- the fluid within the channel may partially or completely fill the channel.
- the fluid may be held or confined within the channel or a portion of the channel in some fashion, for example, using surface tension (i.e., such that the fluid is held within the channel within a meniscus, such as a concave or convex meniscus).
- the channel may have any suitable cross-sectional shape that allows for fluid transport, for example, a square channel, a circular channel, a rounded channel, a rectangular channel (e.g., having any aspect ratio), a triangular channel, an irregular channel, etc.
- the channel may be of any size.
- the channel may have a largest dimension perpendicular to a direction of fluid flow within the channel of less than about 1000 micrometers in some cases (i.e., a microfluidic channel), less than about 500 micrometers in other cases, less than about 400 micrometers in other cases, less than about 300 micrometers in other cases, less than about 200 micrometers in still other cases, less than about 100 micrometers in still other cases, or less than about 50 or 25 micrometers in still other cases.
- the dimensions of the channel may be chosen such that fluid is able to freely flow through the channel.
- the dimensions of the channel may also be chosen in certain cases, for example, to allow a certain volumetric or linear flowrate of fluid within the channel.
- the number of channels, the shape or geometry of the channels, and the placement of channels can be determined by those of ordinary skill in the art.
- One or more different nanoscale wires may cross the same microfluidic channel (e.g., at different positions) to detect the same or different analytes, to measure a flowrate of an analyte(s), etc.
- one or more nanoscale wires may be positioned in a microfluidic channel to form one of a plurality of analytic elements, for instance, in a microneedle probe, a dip and read probe, etc.
- the analytic elements probe may be implantable and capable of detecting several analytes simultaneously in real time, according to certain embodiments.
- one or more nanoscale wires may be positioned in a microfluidic channel to form an analytic element in a microarray for a cassette or a lab-on-a-chip device.
- cassette or lab-on-a-chip devices that are suitable for high- throughout chemical analysis and screening, combinational drug discovery, etc.
- the ability to include multiple nanoscale wires in one nanoscale sensor also allows, in some cases, for the simultaneous detection of different analytes suspected of being present in a single sample, i.e., the nanoscale sensor allows "multiplexed" detection of different analytes.
- a nanoscale sensor may include a plurality of nanoscale wires that each detect different pH levels, proteins, enzymes, toxins, small molecules, and/or nucleic acids, etc.
- the sensing element may comprise a plurality of nanoscale wires able to determine (i.e., detect the presence, absence, and/or amount or concentration) one or more analytes within a sample, for example, from a liquid or solution, blood serum, etc., as previously described.
- Various nanoscale wires within the sensing element may be differentially doped as described herein, and/or contain different reaction entities, and/or the same reaction entities at different concentrations, thereby varying the sensitivity of the nanoscale wires to the analytes, as needed.
- different reaction entities may be "printed" on the nanoscale wires, e.g., using microarray printing techniques or the like, thereby producing an array of nanoscale wires comprising different reaction entities.
- individual nanoscale wires may be selected based on their ability to interact with specific analytes, thereby allowing the detection of a variety of analytes.
- the plurality of nanoscale wires may be randomly oriented or parallel to one another, according to another set of embodiments.
- the plurality of nanoscale wires may also be oriented in an array on a substrate, in specific instances.
- a sensing element of the present invention can collect real time data and/or near- real time data, in some embodiments.
- the data may be used, for example, to monitor the reaction rate of a specific chemical or biological reaction.
- Physiological conditions or drug concentrations present in vivo may also produce a real time (or near-real time) signal that may be used to control a drug delivery system, in another embodiment of the invention.
- electrical determination of one or more properties of the nanoscale wire may allow for the determination of one or more analytes as a function of time.
- the conductance of a nanoscale wire may be determined as a function of time, which may give additional information regarding the analyte.
- the nanoscale wires may be individually addressable, i.e., the status of the nanoscale wire may be determined without determining the status of nearby nanoscale wires.
- a nanoscale wire within a sensing element, or a number of nanoscale wires within the sensing element may be in electrical communication with an electrode that is able to address the nanoscale wire(s), and such a wire may be addressed using the electrode without addressing other nanoscale wires not in electrical communication with the electrode.
- a first reaction entity immobilized relative to a first nanoscale wire may bind an analyte, and such a binding event may be detectable independently of the detection of a binding event involving a second reaction entity immobilized relative to a second nanoscale wire.
- the electrodes may be in electronic communication with one or more electrical contacts.
- the invention includes a microarray including a plurality of sensing regions, at least some of which comprise one or more nanoscale wires.
- the microarray including some or all of the sensing regions, may define a sensing element in a sensor device.
- At least some of the nanoscale wires are able to determine an analyte suspected to be present in a sample that the sensing region of the microarray is exposed to, for example, the nanoscale wire may comprise a reaction entity able to interact with an analyte. If more than one nanoscale wire is present within the sensing region, the nanoscale wires may be able to detect the same analyte and/or different analytes, depending on the application.
- an article of the invention may comprise a cassette comprising a sensing element having a sample exposure region and a nanoscale wire.
- the detection of an analyte in a sample within the sample exposure region may occur, in some cases, while the cassette is disconnected to a detector apparatus, allowing samples to be gathered at one site, and determined at another.
- the cassette may then be operatively connectable to a detector apparatus able to determine a property associated with the nanoscale wire.
- a device is "operatively connectable" when it has the ability to attach and interact with another apparatus.
- the cassette may be constructed and arranged such that samples may be gathered and determination at one site.
- the present invention includes, in some embodiments, an integrated system comprising a nanoscale wire detector, a reader, and a computer controlled response system.
- the nanoscale wire detects a change in the equilibrium or concentration of an analyte in the sample, feeding a signal to the computer controlled response system, causing it to withhold or release a chemical or drug.
- This is useful as an implantable drug or chemical delivery system because of its small size and low energy requirements.
- any of the techniques described herein may be used in the determination of proteins, enzymes, toxins, viruses, small molecules, or the like, e.g., as in an assay, for example, to detect or diagnose cancer or other medical conditions, toxins or other environmental agents, viruses, or the like.
- a property of an analyte may be determined by allowing the analyte to interact with a nanoscale wire and/or a reaction entity, and the interaction may be analyzed or determined in some fashion, e.g., quantified.
- the degree or amount of interaction may be determined, for example, by measuring a property of the nanoscale wire (e.g., an electronic property, such as the conductance) after exposing the nanoscale wire and/or the reaction entity to the analyte.
- a property of the nanoscale wire e.g., an electronic property, such as the conductance
- a protein, enzyme, or other target molecule may be immobilized relative to a nanoscale wire as a reaction entity, and exposed to one or more drug candidates, for example, serially or simultaneously. Interaction of the drug candidate(s) with the reaction entity may be determined by determining a property of the nanoscale wire, e.g., as previously described.
- a nanoscale wire having an associated reaction entity, may be exposed to one or more species able to interact with the reaction entity, for instance, the nanoscale wire may be exposed to a sample containing a first species able to interact with the reaction entity, where the sample contains or is suspected of containing a second species able to interact with the reaction entity, and optionally other, different species, where one of the species is a drug candidate.
- the sample may contain a substrate and a drug candidate suspected of interacting with the enzyme in a way that inhibits enzyme/substrate interaction; if the reaction entity is a substrate, the sample may contain an enzyme and a drug candidate suspected of interacting with the substrate in an inhibitory manner; if the reaction entity is a nucleic acid, the sample may contain an enzyme able to bind the nucleic acid (e.g., a nucleic acid synthesis enzyme), or a complementary nucleic acid, and a drug candidate suspected of interacting with the nucleic acid reaction entity in an inhibitory manner; if the reaction entity is a receptor, the sample may contain a ligand for the receptor and a drug candidate suspected of interacting with the receptor in an inhibitory manner; etc.
- the reaction entity is an enzyme
- the sample may contain a substrate and a drug candidate suspected of interacting with the enzyme in a way that inhibits enzyme/substrate interaction
- the reaction entity if the reaction entity is a substrate, the sample may contain an enzyme and a
- the drug candidate may also act in a way that enhances, rather than inhibits, interaction.
- assays of the invention may be used in high-throughput screening applications, e.g., where at least 100, at least 1,000, at least 10,000, or at least 100,000 or more analytes may be rapidly screened, for example, by exposing one or more analytes to a nanoscale wire (e.g., in solution), and/or exposing a plurality of analytes to a plurality of nanoscale wires and/or reaction entities.
- Certain aspects of the present invention include a nanoscopic wire or other nanostructured material comprising one or more semiconductor and/or metal compounds, for example, for use in any of the above-described embodiments.
- the semiconductors and/or metals may be chemically and/or physically combined, for example, as in a doped nanoscopic wire.
- the nanoscopic wire may be, for example, a nanorod, a nanowire, a nanowhisker, or a nanotube.
- the nanoscopic wire may be used in a device, for example, as a semiconductor component, a pathway, etc.
- nanoscale wires and other conductors or semiconductors for use in the invention are based, in some instances, upon whether the nanoscale wire is able to interact with an analyte, or whether the appropriate reaction entity, e.g. a binding partner, can be easily attached to the surface of the nanoscale wire, or the appropriate reaction entity, e.g. a binding partner, is near the surface of the nanoscale wire.
- suitable conductors or semiconductors, including nanoscale wires will be apparent and readily reproducible by those of ordinary skill in the art with the benefit of the present disclosure.
- nanoscopic wires as used in accordance with the present invention are individual nanoscopic wires.
- "individual nanoscopic wire” means a nanoscopic wire free of contact with another nanoscopic wire (but not excluding contact of a type that may be desired between individual nanoscopic wires, e.g., as in a crossbar array).
- an "individual” or a “free-standing” article may, at some point in its life, not be attached to another article, for example, with another nanoscopic wire, or the free-standing article may be in solution.
- nanotubes produced primarily by laser vaporization techniques that produce materials formed as ropes having diameters of about 2 nm to about 50 nm or more and containing many individual nanotubes.
- conductive portions of articles which differ from surrounding material only by having been altered chemically or physically, in situ, i.e., where a portion of a uniform article is made different from its surroundings by selective doping, etching, etc.
- An "individual” or a “free-standing” article is one that can be (but need not be) removed from the location where it is made, as an individual article, and transported to a different location and combined with different components to make a functional device such as those described herein and those that would be contemplated by those of ordinary skill in the art upon reading this disclosure.
- the nanoscopic wire may include additional materials, such as semiconductor materials, dopants, organic compounds, inorganic compounds, etc.
- additional materials such as semiconductor materials, dopants, organic compounds, inorganic compounds, etc.
- the following are non-limiting examples of materials that may be used as dopants within the nanoscopic wire.
- the dopant may be an elemental semiconductor, for example, silicon, germanium, tin, selenium, tellurium, boron, diamond, or phosphorous.
- the dopant may also be a solid solution of various elemental semiconductors.
- the dopant may include mixtures of Group IV elements, for example, a mixture of silicon and carbon, or a mixture of silicon and germanium.
- the dopant may include mixtures of Group III and Group V elements, for example, BN, BP, BAs, AlN, AlP, AlAs, AlSb, GaN, GaP, GaAs, GaSb, InN, InP, InAs, or InSb.
- the dopants may include mixtures of Group III and Group V elements.
- the mixtures may include AlGaN, GaPAs, InPAs, GaInN, AlGaInN, GaInAsP, or the like.
- the dopants may also include mixtures of Group II and Group VI elements.
- the dopant may include mixtures of ZnO, ZnS, ZnSe, ZnTe, CdS, CdSe, CdTe, HgS, HgSe, HgTe, BeS, BeSe, BeTe, MgS, MgSe, or the like. Alloys or mixtures of these dopants are also be possible, for example, ZnCd Se, or ZnSSe or the like. Additionally, mixtures of different groups of semiconductors may also be possible, for example, combinations of Group II-Group VI and Group Ill-Group V elements, such as (GaAs) x (ZnS) 1-x .
- dopants may include mixtures of Group IV and Group VI elements, for example GeS, GeSe, GeTe, SnS, SnSe, SnTe, PbO, PbS, PbSe, PbTe, etc.
- Other dopant mixtures may include mixtures of Group I elements and Group VII elements, such as CuF, CuCl, CuBr, CuI, AgF, AgCl, AgBr, AgI, or the like.
- dopant mixtures may include different mixtures of these elements, such as BeSiN 2 , CaCN 2 , ZnGeP 2 , CdSnAs 2 , ZnSnSb 2 , CuGeP 3 , CuSi 2 P 3 , Si 3 N 4 , Ge 3 N 4 , Al 2 O 3 , (Al, Ga, In) 2 (S, Se, Te) 3 , Al 2 CO, (Cu, Ag)(Al, Ga, In, Tl, Fe)(S, Se, Te) 2 or the like.
- these elements such as BeSiN 2 , CaCN 2 , ZnGeP 2 , CdSnAs 2 , ZnSnSb 2 , CuGeP 3 , CuSi 2 P 3 , Si 3 N 4 , Ge 3 N 4 , Al 2 O 3 , (Al, Ga, In) 2 (S, Se, Te) 3 , Al 2 CO, (Cu, Ag)(Al, Ga, In, T
- a p-type dopant may be selected from Group III, and an n-type dopant may be selected from Group V.
- a p-type dopant may include at least one of B, Al and In, and an n-type dopant may include at least one of P, As and Sb.
- a p-type dopant may be selected from Group II, including one or more of Mg, Zn, Cd and Hg, or Group IV, including one or more of C and Si.
- An n-type dopant may be selected from at least one of Si, Ge, Sn, S, Se and Te. It will be understood that the invention is not limited to these dopants, but may include other elements, alloys, or mixtures as well.
- the term "Group,” with reference to the Periodic Table, is given its usual definition as understood by one of ordinary skill in the art.
- the Group II elements include Mg and Ca, as well as the Group II transition elements, such as Zn, Cd, and Hg.
- the Group III elements include B, Al, Ga, In and Tl;
- the Group IV elements include C, Si, Ge, Sn, and Pb;
- the Group V elements include N, P, As, Sb and Bi;
- the Group VI elements include O, S, Se, Te and Po. Combinations involving more than one element from each Group are also possible.
- a Group II- VI material may include at least one element from Group II and at least one element from Group VI, e.g., ZnS, ZnSe, ZnSSe, ZnCdS, CdS, or CdSe.
- a Group IH-V material may include at least one element from Group III and at least one element from Group V, for example GaAs, GaP, GaAsP, InAs, InP, AlGaAs, or InAsP.
- Other dopants may also be included with these materials and combinations thereof, for example, transition metals such as Fe, Co, Te, Au, and the like.
- the nanoscale wire of the present invention may further include, in some cases, any organic or inorganic molecules. In some cases, the organic or inorganic molecules are polarizable and/or have multiple charge states.
- a nanoscopic wire may be a bulk- doped semiconductor.
- a "bulk-doped" article e. g. an article, or a section or region of an article
- a dopant is incorporated substantially throughout the crystalline lattice of the article, as opposed to an article in which a dopant is only incorporated in particular regions of the crystal lattice at the atomic scale, for example, only on the surface or exterior.
- some articles such as carbon nanotubes are typically doped after the base material is grown, and thus the dopant only extends a finite distance from the surface or exterior into the interior of the crystalline lattice.
- a bulk-doped semiconductor may comprise two or more bulk-doped regions.
- doped refers to bulk-doped nanoscopic wires, and, accordingly, a “doped nanoscopic (or nanoscale) wire” is a bulk-doped nanoscopic wire.
- Heavily doped and “lightly doped” are terms the meanings of which are understood by those of ordinary skill in the art.
- the invention includes a nanoscale wire (or other nanostructured material) that is a single crystal.
- a "single crystal" item e.g., a semiconductor
- Such a single-crystal item may include defects in the crystal, but is to be distinguished from an item that includes one or more crystals, not ionically or covalently bonded, but merely in close proximity to one another.
- the nanoscale wire may comprise two or more regions having different compositions.
- Each region of the nanoscale wire may have any shape or dimension, and these can be the same or different between regions.
- a region may have a smallest dimension of less than 1 micron, less than 100 nm, less than 10 nm, or less than 1 run.
- one or more regions may be a single monolayer of atoms (i.e., "delta-doping").
- the region may be less than a single monolayer thick (for example, if some of the atoms within the monolayer are absent).
- the two or more regions may be longitudinally arranged relative to each other, and/or radially arranged (e.g., as in a core/shell arrangement) within the nanoscale wire.
- the nanoscale wire may have multiple regions of semiconductor materials arranged longitudinally.
- a nanoscale wire may have two regions having different compositions arranged longitudinally, surrounded by a third region or several regions, each having a composition different from that of the other regions.
- the regions may be arranged in a layered structure within the nanoscale wire, and one or more of the regions may be delta-doped or at least partially delta-doped.
- the nanoscale wire may have a series of regions positioned both longitudinally and radially relative to each other.
- the arrangement can include a core that differs in composition along its length (changes in composition or concentration longitudinally), while the lateral (radial) dimensions of the core do, or do not, change over the portion of the length differing in composition.
- the shell portions can be adjacent each other (contacting each other, or defining a change in composition or concentration of a unitary shell structure longitudinally), or can be separated from each other by, for example, air, an insulator, a fluid, or an auxiliary, non- nanoscale wire component.
- the shell portions can be positioned directly on the core, or can be separated from the core by one or more intermediate shells portions that can themselves be constant in composition longitudinally, or varying in composition longitudinally, i.e., the invention allows the provision of any combination of a nanowire core and any number of radially-positioned shells (e.g., concentric shells), where the core and/or any shells can vary in composition and/or concentration longitudinally, any shell sections can be spaced from any other shell sections longitudinally, and different numbers of shells can be provided at different locations longitudinally along the structure.
- a nanoscale wire may be positioned proximate the surface of a substrate, i.e., the nanoscale wire may be positioned within about 50 nm, about 25 nm, about 10 nm, or about 5 nm of the substrate. In some cases, the proximate nanoscale wire may contact at least a portion of the substrate.
- the substrate comprises a semiconductor and/or a metal. Non-limiting examples include Si, Ge, GaAs, etc. Other suitable semiconductors and/or metals are described above with reference to nanoscale wires.
- the substrate may comprise a nonmetal/nonsemiconductor material, for example, a glass, a plastic or a polymer, a gel, a thin film, etc.
- a nonmetal/nonsemiconductor material for example, a glass, a plastic or a polymer, a gel, a thin film, etc.
- suitable polymers include polyethylene, polypropylene, poly(ethylene terephthalate), polydimethylsiloxane, or the like.
- the present invention provides a method of preparing a nanostructure.
- the method involves allowing a first material to diffuse into at least part of a second material, optionally creating a new compound.
- the first and second materials may each be metals or semiconductors, one material may be a metal and the other material may be a semiconductor, etc.
- a semiconductor may be annealed to a metal. For example, a portion of the semiconductor and/or a portion of the metal may be heated such that at least some metal atoms are able to diffuse into the semiconductor, or vice versa.
- a metal electrode e.g., a nickel, gold, copper, silver, chromium electrode, etc.
- a metal electrode may be positioned in physical contact with a semiconductor nanoscopic wire, and then annealed such that at least a portion of the semiconductor diffuses into at least a portion of the metal, optionally forming a metal-semiconductor compound, e.g., as disclosed in International Patent Application No. PCT/US2005/004459, filed February 14, 2005, entitled “Nano structures Containing Metal-Semiconductor Compounds," by Lieber, et al, incorporated herein by reference.
- the semiconductor may be annealed with the metal at a temperature of about 300 0 C, about 350 0 C, about 400 0 C, about 450 0 C, about 500 0 C, about 550 0 C, or about 600 0 C for a period of time of at least about 30 minutes, at least about 1 hour, at least about 2 hours, at least about 4 hours, at least about 6 hours etc.
- annealing may allow, for example, lower contact resistances or impedances between the metal and the semiconductor.
- the metal may be passivated, e.g., as described herein.
- the metal, or at least a portion of the metal may be exposed to one or more passivating agents, for example, Si 3 N 4 . Insulation of the metal by the passivating agent may be used to form a layer covering the surface of the metal, for example, to prevent reaction or nonspecific binding between an analyte and the metal.
- a metal electrode may be in electrical communication with a semiconductor comprising one or more immobilized reaction entities, and the metal electrode may be passivated to prevent a reaction or nonspecific binding between the metal and the reaction entity, and/or to reduce or prevent leakage current from the metal.
- the passivation may be conducted at a relatively high temperature, for example, within a plasma CVD chamber.
- the present invention involves controlling and altering the doping of semiconductors in a nanoscale wire.
- the nanoscale wires may be produced using techniques that allow for direct and controlled growth of the nanoscale wires.
- the nanoscale wire may be doped during growth of the nanoscale wire. Doping the nanoscale wire during growth may result in the property that the doped nanoscale wire is bulk-doped.
- doped nanoscale wires may be controllably doped, such that a concentration of a dopant within the doped nanoscale wire can be controlled and therefore reproduced consistently.
- Nanoscopic wires may also be grown through laser catalytic growth.
- LCG metal-catalyzed CVD techniques
- nanoscale wires with uniform size (diameter) distribution can be produced, where the diameter of the wires is determined by the size of the catalytic clusters.
- Nanoscale wires may be doped by introducing the doping element into the vapor phase reactant (e.g. diborane and phosphane).
- the doping concentration may be controlled by controlling the relative amount of the doping compound introduced in the composite target.
- the final doping concentration or ratios are not necessarily the same as the vapor-phase concentration or ratios.
- LCG laser catalytic growth
- a desired material e.g. silicon or indium phosphide
- a catalytic material e.g. a nanoparticle catalyst
- the vapor may condense into liquid nanoclusters through collision with a buffer gas. Growth may begin when the liquid nanoclusters become supersaturated with the desired phase and can continue as long as reactant is available. Growth may terminate when the nanoscale wire passes out of the hot reaction zone and/or when the temperature is decreased.
- the nanoscale wire may be further subjected to different semiconductor reagents during growth.
- nanoscale wires of any of a variety of materials may be grown directly from vapor phase through a vapor-solid process.
- nanoscale wires may also be produced by deposition on the edge of surface steps, or other types of patterned surfaces.
- nanoscale wires may be grown by vapor deposition in or on any generally elongated template.
- the porous membrane may be porous silicon, anodic alumina, a diblock copolymer, or any other similar structure.
- the natural fiber may be DNA molecules, protein molecules carbon nanotubes, any other elongated structures.
- the source materials may be a solution or a vapor.
- the template may also include be column micelles formed by surfactant.
- the nanoscale wire may be doped after formation.
- a nanoscale wire having a substantially homogeneous composition is first synthesized, then is doped post-synthetically with various dopants. Such doping may occur throughout the entire nanoscale wire, or in one or more portions of the nanoscale wire, for example, in a wire having multiple regions differing in composition.
- One aspect of the invention provides for the assembly, or controlled placement, of nanoscale wires on a surface.
- Any substrate may be used for nanoscale wire placement, for example, a substrate comprising a semiconductor, a substrate comprising a metal, a substrate comprising a glass, a substrate comprising a polymer, a substrate comprising a gel, a substrate that is a thin film, a substantially transparent substrate, a non-planar substrate, a flexible substrate, a curved substrate, etc.
- assembly can be carried out by aligning nanoscale wires using an electrical field.
- assembly can be performed using an arrangement involving positioning a fluid flow directing apparatus to direct fluid containing suspended nanoscale wires toward and in the direction of alignment with locations at which nanoscale wires are desirably positioned.
- a nanoscale wire (or other nanostructure) is formed on the surface of a substrate, and/or is defined by a feature on a substrate.
- a nanostructure such as a nanoscale wire, is formed as follows. A substrate is imprinted using a stamp or other applicator to define a pattern, such as a nanoscale wire or other nanoscale structure.
- the imprintable layer is removed, for example, through etching processes such as reactive ion etching (RIE), or other known techniques.
- RIE reactive ion etching
- enough imprintable material may be removed from the substrate so as to expose portions of the substrate free of the imprintable material.
- a metal or other materials may then be deposited onto at least a portion of the substrate, for example, gold, copper, silver, chromium, etc.
- a "lift-off step may then be performed, where at least a portion of the imprintable material is removed from the substrate.
- Metal or other material deposited onto the imprintable material may be removed along with the removal of the imprintable material, for example, to form one or more nanoscale wires.
- the substrate may be any suitable substrate that can support an imprintable layer, for example, comprising a semiconductor, a metal, a glass, a polymer, a gel, etc.
- the substrate may be a thin film, substantially transparent, non-planar, flexible, and/or curved, etc.
- an array of nanoscale wires may be produced by providing a surface having a plurality of substantially aligned nanoscale wires, and removing, from the surface, a portion of one or more of the plurality of nanoscale wires. The remaining nanoscale wires on the surface may then be connected to one or more electrodes.
- the nanoscopic wires are arranged such that they are in contact with each other; in other instances, however, the aligned nanoscopic wires may be at a pitch such that they are substantially not in physical contact.
- nanoscale wires are positioned proximate a surface using flow techniques, i.e., techniques where one or more nanoscale wires may be carried by a fluid to a substrate.
- Nanoscale wires (or any other elongated structures) can be aligned by inducing a flow of a nanoscale wire solution on surface, where the flow can include channel flow or flow by any other suitable technique.
- Nanoscale wire arrays with controlled position and periodicity can be produced by patterning a surface of a substrate and/or conditioning the surface of the nanoscale wires with different functionalities, where the position and periodicity control may be achieved by designing specific complementary forces between the patterned surface and the nanoscale wires.
- Nanoscale wires can also be assembled using a Langmuir-Blodgett (LB) trough. Nanoscale wires may first be surface-conditioned and dispersed to the surface of a liquid phase to form a Langmuir-Blodgett film.
- the liquid may include a surfactant, which can, in some cases, reduce aggregation of the nanoscale wires and/or reduce the ability of the nanoscale wires to interact with each other.
- the nanoscale wires can be aligned into different patterns (such as parallel arrays or fibers) by compressing the surface or reducing the surface area of the surface.
- Another arrangement involves forming surfaces on a substrate including regions that selectively attract nanoscale wires surrounded by regions that do not selectively attract them.
- Surfaces can be patterned using known techniques such as electron-beam patterning, "soft-lithography” such as that described in International Patent Application Serial No. PCT/US96/03073, entitled “Microcontact Printing on Surfaces and Derivative Articles,” filed March 1, 1996, published as Publication No. WO 96/29629 on July 26, 1996; or U.S. Patent No. 5,512,131, entitled “Formation of Microstamped Patterns on Surfaces and Derivative Articles,” issued April 30, 1996, each of which is incorporated herein by reference. Additional techniques are described in U.S. Patent Application Serial No.
- Fluid flow channels can be created at a size scale advantageous for placement of nanoscale wires on surfaces using a variety of techniques such as those described in International Patent Application Serial No. PCT/US97/04005, entitled “Method of Forming Articles and Patterning Surfaces via Capillary Micromolding,” filed March 14, 1997, published as Publication No. WO 97/33737 on September 18, 1997, and incorporated herein by reference.
- Other techniques include those described in U.S. Patent No. 6,645,432, entitled “Microfluidic Systems Including Three-dimensionally Arrayed Channel Networks,” issued November 11, 2003, incorporated herein by reference.
- Chemically patterned surfaces other than SAM-derivatized surfaces can be used, and many techniques for chemically patterning surfaces are known.
- Another example of a chemically patterned surface may be a micro-phase separated block copolymer structure. These structures may provide a stack of dense lamellar phases, where a cut through these phases reveals a series of "lanes" wherein each lane represents a single layer.
- the assembly of nanoscale wires onto substrate and electrodes can also be assisted using bimolecular recognition in some cases.
- one biological binding partner may be immobilized onto the nanoscale wire surface and the other one onto a substrate or an electrode using physical adsorption or covalently linking.
- SAMs self-assembled monolayers.
- Any of a variety of substrates and S AM-forming material can be used along with microcontact printing techniques, such as those described in International Patent Application Serial No. PCT/US96/03073, entitled “Microcontact Printing on Surfaces and Derivative Articles,” filed March 1, 1996, published as Publication No. WO 96/29629 on July 26, 1996, incorporated herein by reference in its entirety.
- the nanoscale wire arrays may also be transferred to another substrate, e.g., by using stamping techniques.
- nanoscale wires may be assembled using complementary interaction, i.e., where one or more complementary chemical, biological, electrostatic, magnetic or optical interactions are used to position one or more nanoscale wires on a substrate.
- physical patterns may be used to position nanoscale wires proximate a surface.
- nanoscale wires may be positioned on a substrate using physical patterns, for instance, aligning the nanoscale wires using corner of the surface steps or along trenches on the substrate.
- the present invention provides any of the above-mentioned devices packaged in kits, optionally including instructions for use of the devices.
- instructions can define a component of instructional utility (e.g., directions, guides, warnings, labels, notes, FAQs ("frequently asked questions"), etc., and typically involve written instructions on or associated with packaging of the invention.
- Instructions can also include instructional communications in any form (e.g., oral, electronic, digital, optical, visual, etc.), provided in any manner such that a user will clearly recognize that the instructions are to be associated with the device, e.g., as discussed herein.
- kit may include other components depending on the specific application, for example, containers, adapters, syringes, needles, replacement parts, etc.
- promoted includes all methods of doing business including, but not limited to, methods of selling, advertising, assigning, licensing, contracting, instructing, educating, researching, importing, exporting, negotiating, financing, loaning, trading, vending, reselling, distributing, replacing, or the like that can be associated with the methods and compositions of the invention, e.g., as discussed herein. Promoting may also include, in some cases, seeking approval from a government agency to sell a composition of the invention for medicinal purposes.
- Methods of promotion can be performed by any party including, but not limited to, businesses (public or private), contractual or sub-contractual agencies, educational institutions such as colleges and universities, research institutions, hospitals or other clinical institutions, governmental agencies, etc.
- Promotional activities may include instructions or communications of any form (e.g., written, oral, and/or electronic communications, such as, but not limited to, e- mail, telephonic, facsimile, Internet, Web-based, etc.) that are clearly associated with the invention.
- Certain devices of the invention may include wires or other components of scale commensurate with nanometer-scale wires, which includes nanotubes and nanowires.
- the invention comprises articles that may be greater than nanometer size (e. g., micrometer-sized).
- nanometer size e. g., micrometer-sized
- “nanoscopic-scale,” “nanoscopic,” “nanometer-scale,” “nanoscale,” the “nano-” prefix (for example, as in “nanostructured”), and the like generally refers to elements or articles having widths or diameters of less than about 1 micron, and less than about 100 nm in some cases.
- specified widths can be a smallest width (i.e.
- the article can have a larger width in a different dimension), or a largest width (i.e. where, at that location, the article has a width that is no wider than as specified, but can have a length that is greater).
- a "wire” generally refers to any material having a conductivity of or of similar magnitude to any semiconductor or any metal, and in some embodiments may be used to connect two electronic components such that they are in electronic communication with each other.
- the terms “electrically conductive” or a “conductor” or an “electrical conductor” when used with reference to a “conducting" wire or a nanoscale wire refers to the ability of that wire to pass charge.
- an electrically conductive nanoscale wire will have a resistivity comparable to that of metal or semiconductor materials, and in some cases, the electrically conductive nanoscale wire may have lower resistivities, for example, resistivities of less than about 100 microOhm cm ( ⁇ cm).
- the electrically conductive nanoscale wire will have a resistivity lower than about 10 "3 ohm meters, lower than about 10 "4 ohm meters, or lower than about 10 "6 ohm meters or 10 ⁇ 7 ohm meters.
- a "semiconductor,” as used herein, is given its ordinary meaning in the art, i.e., an element having semiconductive or semi-metallic properties (i.e., between metallic and non-metallic properties).
- An example of a semiconductor is silicon.
- Other non-limiting examples include gallium, germanium, diamond (carbon), tin, selenium, tellurium, boron, or phosphorous.
- a “nanoscopic wire” (also known herein as a “nanoscopic-scale wire” or “nanoscale wire”) generally is a wire, that at any point along its length, has at least one cross-sectional dimension and, in some embodiments, two orthogonal cross-sectional dimensions less than 1 micron, less than about 500 nm, less than about 200 nm, less than about 150 nm, less than about 100 nm, less than about 70, less than about 50 nm, less than about 20 nm, less than about 10 nm, or less than about 5 nm. In other embodiments, the cross-sectional dimension can be less than 2 nm or 1 nm.
- the nanoscale wire has at least one cross-sectional dimension ranging from 0.5 nm to 100 nm or 200 nm.
- the nanoscale wire is electrically conductive.
- the cross-section of a nanoscopic wire may be of any arbitrary shape, including, but not limited to, circular, square, rectangular, annular, polygonal, or elliptical, and may be a regular or an irregular shape.
- the nanoscale wire may be solid or hollow. A non-limiting list of examples of materials from which nanoscale wires of the invention can be made appears below.
- any nanoscale wire can be used in any of the embodiments described herein, including carbon nanotubes, molecular wires (i.e., wires formed of a single molecule), nanorods, nanowires, nanowhiskers, organic or inorganic conductive or semiconducting polymers, and the like, unless otherwise specified.
- Other conductive or semiconducting elements that may not be molecular wires, but are of various small nanoscopic-scale dimensions, can also be used in some instances, e.g. inorganic structures such as main group and metal atom-based wire-like silicon, transition metal-containing wires, gallium arsenide, gallium nitride, indium phosphide, germanium, cadmium selenide, etc.
- nanoscale wires can be grown on and/or applied to surfaces in patterns useful for electronic devices in a manner similar to techniques described herein involving the specific nanoscale wires used as examples, without undue experimentation.
- the nanoscale wires may be formed having dimensions of at least about 1 micron, at least about 3 microns, at least about 5 microns, or at least about 10 microns or about 20 microns in length, and can be less than about 100 nm, less than about 80 run, less than about 60 nm, less than about 40 nm, less than about 20 nm, less than about 10 nm, or less than about 5 nm in thickness (height and width).
- the nanoscale wires may have an aspect ratio (length to thickness) of greater than about 2:1, greater than about 3:1, greater than about 4:1, greater than about 5:1, greater than about 10:1, greater than about 25:1, greater than about 50:1, greater than about 75:1, greater than about 100:1, greater than about 150:1, greater than about 250:1, greater than about 500:1, greater than about 750:1, or greater than about 1000:1 or more in some cases.
- a “nanowire” (e. g. comprising silicon and/or another semiconductor material) is a nanoscopic wire that is typically a solid wire, and may be elongated in some cases.
- a nanowire (which is abbreviated herein as "NW”) is an elongated semiconductor, i.e., a nanoscale semiconductor.
- a “non-nanotube nanowire” is any nanowire that is not a nanotube.
- a non- nanotube nanowire having an unmodified surface (not including an auxiliary reaction entity not inherent in the nanotube in the environment in which it is positioned) is used in any arrangement of the invention described herein in which a nanowire or nanotube can be used.
- a “nanotube” e.g. a carbon nanotube
- NT nanotube
- Nanotubes are used as one example of small wires for use in the invention and, in certain embodiments, devices of the invention include wires of scale commensurate with nanotubes.
- Examples of nanotubes that may be used in the present invention include, but are not limited to, single-walled nanotubes (SWNTs). Structurally, SWNTs are formed of a single graphene sheet rolled into a seamless tube.
- SWNTs single-walled nanotubes
- SWNTs can behave as one-dimensional metals and/or semiconductors.
- SWNTs can behave as one-dimensional metals and/or semiconductors.
- Methods of manufacture of nanotubes, including SWNTs, and characterization are known.
- Methods of selective functionalization on the ends and/or sides of nanotubes also are known, and the present invention makes use of these capabilities for molecular electronics in certain embodiments.
- Multi-walled nanotubes are well known, and can be used as well.
- an "elongated" article e.g. a semiconductor or a section thereof
- an "elongated" article is an article for which, at any point along the longitudinal axis of the article, the ratio of the length of the article to the largest width at that point is greater than 2:1.
- a “width” of an article is the distance of a straight line from a point on a perimeter of the article, through the center of the article, to another point on the perimeter of the article.
- a “width” or a “cross-sectional dimension" at a point along a longitudinal axis of an article is the distance along a straight line that passes through the center of a cross-section of the article at that point and connects two points on the perimeter of the cross-section.
- the "cross-section" at a point along the longitudinal axis of an article is a plane at that point that crosses the article and is orthogonal to the longitudinal axis of the article.
- the "longitudinal axis" of an article is the axis along the largest dimension of the article.
- a “longitudinal section” of an article is a portion of the article along the longitudinal axis of the article that can have any length greater than zero and less than or equal to the length of the article.
- the "length" of an elongated article is a distance along the longitudinal axis from end to end of the article.
- a “cylindrical" article is an article having an exterior shaped like a cylinder, but does not define or reflect any properties regarding the interior of the article. In other words, a cylindrical article may have a solid interior, may have a hollowed-out interior, etc.
- a cross-section of a cylindrical article appears to be circular or approximately circular, but other cross-sectional shapes are also possible, such as a hexagonal shape.
- the cross-section may have any arbitrary shape, including, but not limited to, square, rectangular, or elliptical. Regular and irregular shapes are also included.
- an "array" of articles comprises a plurality of the articles, for example, a series of aligned nanoscale wires, which may or may not be in contact with each other.
- a "crossed array” or a “crossbar array” is an array where at least one of the articles contacts either another of the articles or a signal node (e.g., an electrode).
- the invention provides, in certain embodiments, a nanoscale wire or wires forming part of a system constructed and arranged to determine an analyte in a sample to which the nanoscale wire(s) is exposed.
- Determine in this context, generally refers to the analysis of a species, for example, quantitatively or qualitatively, and/or the detection of the presence or absence of the species. “Determining” may also refer to the analysis of an interaction between two or more species, for example, quantitatively or qualitatively, and/or by detecting the presence or absence of the interaction, e.g. determination of the binding between two species. As an example, an analyte may cause a determinable change in an electrical property of a nanoscale wire (e.g., electrical conductivity, resistivity, impedance, etc.), a change in an optical property of the nanoscale wire, etc.
- an electrical property of a nanoscale wire e.g., electrical conductivity, resistivity, impedance, etc.
- determination techniques include, but are not limited to, piezoelectric measurement, electrochemical measurement, electromagnetic measurement, photodetection, mechanical measurement, acoustic measurement, gravimetric measurement, and the like. “Determining” also means detecting or quantifying interaction between species.
- a "fluid,” as used herein, generally refers to a substance that tends to flow and to conform to the outline of its container.
- fluids are materials that are unable to withstand a static shear stress. When a shear stress is applied to a fluid, it experiences a continuing and permanent distortion.
- Typical fluids include liquids and gases, but may also include free-flowing solid particles, viscoelastic fluids, and the like.
- a component that is "immobilized relative to" another component either is fastened to the other component or is indirectly fastened to the other component, e.g., by being fastened to a third component to which the other component also is fastened.
- a first entity is immobilized relative to a second entity if a species fastened to the surface of the first entity attaches to an entity, and a species on the surface of the second entity attaches to the same entity, where the entity can be a single entity, a complex entity of multiple species, another particle, etc.
- a component that is immobilized relative to another component is immobilized using bonds that are stable, for example, in solution or suspension.
- non-specific binding of a component to another component is not preferred.
- fastened to or adapted to be fastened to as used in the context of a species relative to another species or a species relative to a surface of an article (such as a nanoscale wire), or to a surface of an article relative to another surface, means that the species and/or surfaces are chemically or biochemically linked to or adapted to be linked to, respectively, each other via covalent attachment, attachment via specific biological binding (e.g., biotin/streptavidin), coordinative bonding such as chelate/metal binding, or the like.
- fastened in this context includes multiple chemical linkages, multiple chemical/biological linkages, etc., including, but not limited to, a binding species such as a peptide synthesized on a nanoscale wire, a binding species specifically biologically coupled to an antibody which is bound to a protein such as protein A, which is attached to a nanoscale wire, a binding species that forms a part of a molecule, which in turn is specifically biologically bound to a binding partner covalently fastened to a surface of a nanoscale wire, etc.
- a species also is adapted to be fastened to a surface if a surface carries a particular nucleotide sequence, and the species includes a complementary nucleotide sequence.
- Specifically fastened or “adapted to be specifically fastened” means a species is chemically or biochemically linked to or adapted to be linked to, respectively, another specimen or to a surface as described above with respect to the definition of "fastened to or adapted to be fastened,” but excluding essentially all non-specific binding.
- Covalently fastened means fastened via essentially nothing other than one or more covalent bonds.
- binding refers to the interaction between a corresponding pair of molecules or surfaces that exhibit mutual affinity or binding capacity, typically due to specific or non-specific binding or interaction, including, but not limited to, biochemical, physiological, and/or chemical interactions.
- Biological binding defines a type of interaction that occurs between pairs of molecules including proteins, nucleic acids, glycoproteins, carbohydrates, hormones and the like.
- binding partner refers to a molecule that can undergo binding with a particular molecule.
- Biological binding partners are examples. For example, Protein A is a binding partner of the biological molecule IgG, and vice versa.
- Binding partners include specific, semi-specific, and non-specific binding partners as known to those of ordinary skill in the art.
- Protein A is usually regarded as a "non-specific" or semi-specific binder.
- binding partner e.g., protein, nucleic acid, antibody, etc.
- a binding partner e.g., protein, nucleic acid, antibody, etc.
- a reaction that is determinative of the presence and/or identity of one or other member of the binding pair in a mixture of heterogeneous molecules (e.g., proteins and other biologies).
- heterogeneous molecules e.g., proteins and other biologies.
- An enzyme would specifically bind to its substrate, a nucleic acid would specifically bind to its complement, an antibody would specifically bind to its antigen.
- nucleic acids that specifically bind (hybridize) to their complement include nucleic acids that specifically bind (hybridize) to their complement, antibodies specifically bind to their antigen, binding pairs such as those described above, and the like.
- the binding may be by one or more of a variety of mechanisms including, but not limited to ionic interactions, and/or covalent interactions, and/or hydrophobic interactions, and/or van der Waals interactions, etc.
- polypeptide polypeptide
- peptide protein
- protein protein
- amino acid polymers in which one or more amino acid residue is an artificial chemical analogue of a corresponding naturally occurring amino acid, as well as to naturally occurring amino acid polymers.
- amino acid polymers in which one or more amino acid residue is an artificial chemical analogue of a corresponding naturally occurring amino acid, as well as to naturally occurring amino acid polymers.
- the term also includes variants on the traditional peptide linkage joining the amino acids making up the polypeptide.
- polynucleotide or “oligonucleotide” or grammatical equivalents generally refer to a polymer of at least two nucleotide bases covalently linked together, which may include, for example, but not limited to, natural nucleosides (e.g., adenosine, thymidine, guanosine, cytidine, uridine, deoxyadenosine, deoxythymidine, deoxyguanosine and deoxycytidine), nucleoside analogs (e.g., 2- aminoadenosine, 2-thiothymidine, inosine, pyrrolopyrimidine, 3-methyladenosine, C5- bromouridine, C5-fluorouridine, C5-iodouridine, C5-propynyluridine, C5- propynylcytidine, C5-methylcytidine, 7-deazaadenos
- natural nucleosides e
- oligonucleotide is a polymer having 20 bases or less
- polynucleotide is a polymer having at least 20 bases.
- Nucleic acids can be single-stranded or double stranded, and will generally contain phosphodiester bonds, although in some cases, as outlined below, nucleic acid analogs are included that may have alternate backbones, comprising, for example, phosphoramide (Beaucage et al. (1993) Tetrahedron 49(10):1925) and references therein; Letsinger (1970) J Org. Chem. 35:3800; SRocl et al. (1977) Eur. J. Biochem. 81: 579; Letsinger et al. (1986) Nucl. Acids Res. 14: 3487; Sawai et al. (1984) Chem. Lett. 805, Letsinger et al. (1988) J.
- an “antibody” refers to a protein or glycoprotein including one or more polypeptides substantially encoded by immunoglobulin genes or fragments of immunoglobulin genes.
- the recognized immunoglobulin genes include the kappa, lambda, alpha, gamma, delta, epsilon and mu constant region genes, as well as myriad immunoglobulin variable region genes.
- Light chains are classified as either kappa or lambda.
- Heavy chains are classified as gamma, mu, alpha, delta, or epsilon, which in turn define the immunoglobulin classes, IgG, IgM, IgA, IgD and IgE, respectively.
- a typical immunoglobulin (antibody) structural unit is known to comprise a tetramer.
- Each tetramer is composed of two identical pairs of polypeptide chains, each pair having one "light” (about 25 kD) and one "heavy” chain (about 50-70 kD).
- the N-terminus of each chain defines a variable region of about 100 to 110 or more amino acids primarily responsible for antigen recognition.
- the terms variable light chain (VL) and variable heavy chain (VH) refer to these light and heavy chains respectively.
- Antibodies exist as intact immunoglobulins or as a number of well characterized fragments produced by digestion with various peptidases. Thus, for example, pepsin digests an antibody below (i.e.
- the F(ab)'2 may be reduced under mild conditions to break the disulfide linkage in the hinge region thereby converting the (Fab')2 dimer into an Fab' monomer.
- the Fab' monomer is essentially a Fab with part of the hinge region (see, Paul (1993) Fundamental Immunology, Raven Press, N. Y. for a more detailed description of other antibody fragments).
- Preferred antibodies include single chain antibodies, e.g., single chain Fv (scFv) antibodies in which a variable heavy and a variable light chain are joined together (directly or through a peptide linker) to form a continuous polypeptide.
- scFv single chain Fv
- quantum dot is known to those of ordinary skill in the art, and generally refers to semiconductor or metal nanoparticles that absorb light and quickly re- emit light in a different color depending on the size of the dot. For example, a 2 nanometer quantum dot emits green light, while a 5 nanometer quantum dot emits red light. Cadmium selenide quantum dot nanocrystals are available from Quantum Dot Corporation of Hayward, California.
- EXAMPLE 1 the sensitivity of a nanowire (NW) field effect transistor (FET) sensor prepared in accordance with one embodiment of the invention is shown to be enhanced in the low carrier concentration regime where the screening length is longer than the radius of the nanowire, and therefore the molecules bound on surface can gate the whole cross-section of nanowire.
- NW nanowire
- FET field effect transistor
- This example also shows that optimization of a nanowire FET structure and operating conditions can provide a significant enhancement of, as well as a fundamental understanding for, the sensitivity of a NW-FET sensor.
- operating in the subthreshold regime was shown in this example to improve the prostate specific antigen (PSA) detection limit down to ⁇ 1.5 fM for a NW-FET sensor with a -0.75 pM detection limit in the linear regime.
- PSA prostate specific antigen
- the sensing mechanism is the field gating effect of charged molecules on the carrier conduction inside NW. Therefore, the highest sensitivity may be achieved when the whole volume of nanodevice is gated by surface charges. This situation may be realized when the carrier screening length is much larger than the radius of the NW, R.
- Conductance changes of NW FETs can be used to detect pH, proteins, and viruses, for example, as is discussed in U.S. Patent Application Serial No. 11/501,466, filed August 9, 2006, entitled “Nanoscale Sensors," by Lieber, et al, incorporated herein by reference.
- Si-NWs used for sensor application often have R on the order of 100 nm, or 10 nm in some cases.
- charged molecules bound on the surface gate the NW within a surface layer of thickness -1-2 nm.
- ⁇ si » R and the whole volume of the NW may be gated by molecules at surface.
- FIG. 1 A schematic comparison between these two scenarios is shown in Fig. 1, together with the screening length in silicon plotted as a function of/?.
- This figure shows the screening length effect on the operation and sensitivity of NW FET sensors.
- the working regime and effectiveness of gating effect induced by molecules at the surface of the NW-FET sensors were determined by the relative magnitude between carrier screening length ⁇ s t and nanowire size (radius) R.
- R carrier screening length
- the amount of band bending at the NW surface is also denoted as surface potential shift ⁇ si-
- carriers in the NW may have long screening length (A$ l »r) and the field effect of surface charges can gate the whole NW, fully utilizing the high surface volume ratio of NW.
- the Fermi level Ep is shifted by ⁇ si, relative to the band edges throughout the whole cross-section of NW.
- AG/G the conductance change of device, is the direct readout measured in the sensing experiments, it is more useful in some instances to characterize the intrinsic sensitivity of the NW FET sensor by AG/G, the percentage in the conductance change.
- AG/G to study the sensitivity has a physically meaningful motivation: it is related to the volume ratio between the part of NW that is gated by surface charges (represented by AG) and the whole body of NW (represented by G).
- Nanowire FET fabrication and electrolyte gating were performed as follows. Silicon nanowires were synthesized by chemical vapor deposition using 10 nm gold nanoparticles as catalysts, with silane as the reactant. Diborane was used during the growth to provide boron as the p-type dopant with a typical B:Si ratio of 1:8000. The FETs were fabricated by photolithography into a patterned array. Nickel (60 nm thick) metal was used as contacts which were passivated/protected from electrolyte by deposition of ⁇ 50 nm thick Si 3 N 4 after nickel evaporation. The distance between the source-drain electrodes for each FET was 2 ⁇ m.
- pH and PSA samples were delivered to the nanowire devices by a microfluidic channel (with a 500 ⁇ m width by 50 ⁇ m height cross-section) made of flexible PDMS polymer channel sealed to the device chip.
- the samples were delivered through inlet/outlet connections in the PDMS polymer by a syringe pump running at typical speed of 0.3 ml/hr.
- a gold metal pad (without Si 3 N 4 passivation) on the chip was used as a global gate electrode for gating all the devices in electrolyte.
- the FET conductance was measured by a lock-in amplifier at a frequency of 17 Hz and biased voltage of 30 mV. Nanowire surface modifications were performed as follows.
- the silicon nanowire surface was modified with 3-aminopropyltriethoxysilane (3APTS) to provide amino groups at the nanowire surface.
- the chip was first reacted with 1% 3 APTS in ethanol for -30 min. Then the chip was rinsed with ethanol and baked at 110 0 C for 5-10 min before conductance measurements.
- APTS 3-aminopropyltriethoxysilane
- a two- step modification process was used to link antibody receptors to nanowire. Aldehyde groups were first linked to the NW surface by reacting with 1% 3- (trimethoxysilyl)propyl aldehyde (United Chemical Technologies) in ethanol for -30 min followed by rinsing with ethanol and baking at 110 0 C for 10 min.
- Anti-PSA (AbI, clone ER-PR8, NeoMarkers) was couple to the aldehyde-terminated nanowire surface by reaction of 100 ⁇ g/ml antibody in a pH 8.4, 10 mM phosphate buffer solution with 4 mM sodium cyanoborohydride for -2 h.
- the silicon oxide (SiO 2 ) surface of boron doped p- type Si-NW was modified with 3-aminopropyltriethoxysilane.
- the protonation/deprotonation of amino (-NH 2 ) and silanol (Si-OH) groups changes the surface charge and surface potential of the NW when the pH of electrolyte solution was varied.
- a gold pad on the chip was used as a gate electrode to gate the NW-FET devices in the electrolyte (inset, Fig. 2A).
- Fig. 2A shows the conductance G vs. the electrolyte gate voltage F g of a p-type NW FET.
- the inset shows a schematic diagram of electrolyte gating. This device has a transconductance -700 nS/V in the linear regime and a subthreshold slope 5-180 mV/decade in the subthreshold regime, with a threshold voltage FT - 0 V.
- the parameter characterizing the FET performance in the subthreshold regime was the subthreshold slope S, which equals the change in F g needed to tune the device conductance G by a factor of about ten.
- a transconductance g m dG/dF g -700 nS/V was determined at F g less than the threshold voltage FT ( ⁇ 0 V for this device), where G depended on F g linearly (the "linear regime" of FET).
- the upper and lower lines in this figure are exponential and linear responses for pH induced surface potential shift of -30 mV/pH.
- the capacitance of the NW, CNW characterizes how much the chemical potential (or the Fermi energy E?) of the carriers shifts with respect to the carrier density change: CNW ⁇ e 2 ⁇ pl ⁇ E ⁇ :.
- C NW decreased quickly as the NW was gated from the linear to the subthreshold regime. For instance, CN W drops from ⁇ 3 x 10 "15 F/ ⁇ m to ⁇ 5 x 10 "18 F/ ⁇ m as p decreased from 1 x 10 19 /cm 3 ( ⁇ si ⁇ l .5 nm) to 1 x 10 16 /cm 3 ( ⁇ S i ⁇ 35 nm).
- NW sensors can also be used in high throughput sensitive detection of complex biomolecules such as proteins.
- This example is a demonstration of biomolecule detection in the subthreshold regime of the NW sensor for a cancer marker protein, prostate specific antigen (PSA).
- PSA detection a p-type Si-NW surface was first modified with aldehyde propyltrimethoxysilane, which provides aldehyde groups at NW surface. The aldehyde terminated NW surface was then covalently linked with PSA antibodies, which act as receptors to detect the PSA molecules in analyte solutions, as shown in Fig. 3 A, which is a schematic of the PS A/PS A- Ab binding/unbinding equilibrium system.
- Fig. 3B presents data on detecting 15 pM PSA at different electrolyte gate voltage F g .
- the increased conductance between the arrows was caused by the binding of negatively charged PSA molecules on the p-type NW surface.
- Another practically useful parameter in sensing experiments is the signal to noise ratio, which also increased in the subthreshold regime, as displayed in the lower panel of Fig. 3C.
- the sensor performance may also be relatively optimized (in terms of the highest ⁇ G/G and signal to noise ratio) in the subthreshold regime, consistent with the above discussion based on the screening length effect on the sensitivity as well as the pH sensing experiments.
- the curves show a minimal PSA detection limit -0.75 pM for this device in the linear regime.
- Eq. Sl can be linearized to:
- ⁇ (r) ⁇ Si x /o(r/ ⁇ si ) / I 0 (R/ ⁇ Si ) (S3).
- / 0 (JC) is the zero-order modified Bessel function of the first kind and ⁇ si is the potential at Si/SiO 2 interface.
- Fig. 5 shows the potential distribution ⁇ (r) inside silicon nanowire at different ratios between the nanowire radius R and the carrier screening length ⁇ si. ⁇ (r) is normalized by its value at surface.
- Eq. S8 gives the charging capacitance of a NW and has the following asymptotic behavior: C N w « e 2 *;?x2 ⁇ i? ⁇ si/kBrfor ⁇ S i «i?; and C N w « e 2 ⁇ p ⁇ ⁇ i? 2 /k B rfor ⁇ S i»i?.
- Eq. S8 at the ⁇ si»i? limit is consistent with the well known compressibility of a non-degenerate electron gas, and remains valid for ID after replacing px ⁇ R 2 with the ID charge density (which can be shown to be true by calculating the exact density dependence of the chemical potential of ID Fermions at finite temperatures).
- the screening length of silicon enters C NW in the expression at the ⁇ si «i? limit accounts for the fact that the chemical potential of carriers in NW only changes inside a layer of thickness ⁇ ⁇ si nearby its surface.
- ⁇ (r) A ⁇ xK 0 (rl ⁇ )IK 0 (Rl ⁇ ), and r ⁇ R (SlO),
- ⁇ is the Debye-Huckel screening length of electrolyte and Ko(x) is the zero-order modified Bessel function of the second kind, which has asymptotic behavior /-o(x) «
- ⁇ n(R/ ⁇ ) length of NW is (denote as DL capacitance C DL ):
- a reference to "A and/or B", when used in conjunction with open-ended language such as “comprising” can refer, in one embodiment, to A only (optionally including elements other than B); in another embodiment, to B only (optionally including elements other than A); in yet another embodiment, to both A and B (optionally including other elements); etc.
- the phrase "at least one,” in reference to a list of one or more elements, should be understood to mean at least one element selected from any one or more of the elements in the list of elements, but not necessarily including at least one of each and every element specifically listed within the list of elements and not excluding any combinations of elements in the list of elements.
- This definition also allows that elements may optionally be present other than the elements specifically identified within the list of elements to which the phrase "at least one" refers, whether related or unrelated to those elements specifically identified.
- At least one of A and B can refer, in one embodiment, to at least one, optionally including more than one, A, with no B present (and optionally including elements other than B); in another embodiment, to at least one, optionally including more than one, B, with no A present (and optionally including elements other than A); in yet another embodiment, to at least one, optionally including more than one, A, and at least one, optionally including more than one, B (and optionally including other elements); etc.
Landscapes
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nanotechnology (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Electrochemistry (AREA)
- Composite Materials (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Materials Engineering (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microelectronics & Electronic Packaging (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Inorganic Chemistry (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86058606P | 2006-11-22 | 2006-11-22 | |
PCT/US2007/024126 WO2008127314A1 (en) | 2006-11-22 | 2007-11-19 | High-sensitivity nanoscale wire sensors |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2095100A1 true EP2095100A1 (en) | 2009-09-02 |
EP2095100B1 EP2095100B1 (en) | 2016-09-21 |
Family
ID=39758418
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP07873479.5A Not-in-force EP2095100B1 (en) | 2006-11-22 | 2007-11-19 | Method of operating a nanowire field effect transistor sensor |
Country Status (3)
Country | Link |
---|---|
US (2) | US8575663B2 (en) |
EP (1) | EP2095100B1 (en) |
WO (1) | WO2008127314A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9488614B2 (en) | 2012-10-16 | 2016-11-08 | Abbott Laboratories | Localized desalting systems and methods |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2298968A3 (en) | 2000-08-22 | 2011-10-05 | President and Fellows of Harvard College | Method for growing nanowires |
ES2312490T3 (en) | 2000-12-11 | 2009-03-01 | President And Fellows Of Harvard College | DEVICE CONTAINING MANOSENSORS TO DETECT AN ANALYTE AND ITS MANUFACTURING METHOD. |
US20100227382A1 (en) | 2005-05-25 | 2010-09-09 | President And Fellows Of Harvard College | Nanoscale sensors |
WO2006132659A2 (en) | 2005-06-06 | 2006-12-14 | President And Fellows Of Harvard College | Nanowire heterostructures |
CA2643997A1 (en) * | 2006-03-15 | 2008-03-06 | President And Fellows Of Harvard College | Nanobioelectronics |
JP2009540333A (en) * | 2006-06-12 | 2009-11-19 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | Nanosensors and related technologies |
US8058640B2 (en) | 2006-09-11 | 2011-11-15 | President And Fellows Of Harvard College | Branched nanoscale wires |
US8575663B2 (en) | 2006-11-22 | 2013-11-05 | President And Fellows Of Harvard College | High-sensitivity nanoscale wire sensors |
WO2009085356A2 (en) * | 2007-10-01 | 2009-07-09 | University Of Southern California Usc Stevens | Methods of using and constructing nanosensor platforms |
WO2010044932A2 (en) * | 2008-07-11 | 2010-04-22 | Cornell University | Nanofluidic channels with integrated charge sensors and methods based thereon |
US20100204062A1 (en) * | 2008-11-07 | 2010-08-12 | University Of Southern California | Calibration methods for multiplexed sensor arrays |
US8421072B2 (en) * | 2008-11-12 | 2013-04-16 | Alcatel Lucent | Electronic device having thermally managed electron path and method of thermal management of very cold electrons |
US20100256344A1 (en) * | 2009-04-03 | 2010-10-07 | University Of Southern California | Surface modification of nanosensor platforms to increase sensitivity and reproducibility |
US9297796B2 (en) | 2009-09-24 | 2016-03-29 | President And Fellows Of Harvard College | Bent nanowires and related probing of species |
CN102959740B (en) * | 2010-09-14 | 2018-08-03 | 原子能与替代能源委员会 | For the photoemissive photoelectric device based on nano wire |
US8399262B2 (en) | 2011-03-23 | 2013-03-19 | Darrel A. Mazzari | Biosensor |
US20120272721A1 (en) * | 2011-04-28 | 2012-11-01 | Stichting Imec Nederland | Device comprising a gas sensor sensitive to the presence of a specific gas, method of manufacturing a gas sensor sensitive to the presence of a specific gas for use in the device and use of the device |
WO2012170630A2 (en) * | 2011-06-10 | 2012-12-13 | President And Fellows Of Harvard College | Nanoscale wires, nanoscale wire fet devices, and nanotube-electronic hybrid devices for sensing and other applications |
US9638717B2 (en) | 2012-05-03 | 2017-05-02 | President And Fellows Of Harvard College | Nanoscale sensors for intracellular and other applications |
JP2015535928A (en) | 2012-09-12 | 2015-12-17 | プレジデント アンド フェローズ オブ ハーバード カレッジ | Nanoscale field effect transistors for biomolecular sensors and other applications |
KR101414131B1 (en) | 2013-01-21 | 2014-07-01 | 한국표준과학연구원 | Electric current device and method for pumping electron using the same |
CA2951945C (en) * | 2014-06-19 | 2023-09-19 | The Board Of Trustees Of The Leland Stanford Junior University | Apparatuses and methods for determining analyte charge |
EP3709017B1 (en) | 2014-10-03 | 2024-01-03 | Graphene-Dx, Inc. | Device for chemical analysis |
US10782285B2 (en) | 2014-10-03 | 2020-09-22 | Rite Taste, LLC | Device and method for chemical analysis |
US10105080B1 (en) | 2014-10-24 | 2018-10-23 | Verily Life Sciences Llc | Interstitial fluid sampling above microneedle array |
US9666748B2 (en) | 2015-01-14 | 2017-05-30 | International Business Machines Corporation | Integrated on chip detector and zero waveguide module structure for use in DNA sequencing |
WO2016160131A1 (en) | 2015-02-10 | 2016-10-06 | Multerra Bio, Inc. | Apparatuses and methods for detecting molecules and binding energy |
WO2017201239A1 (en) * | 2016-05-18 | 2017-11-23 | Integrated Nano-Technologies, Inc. | Method for detection of a pcr product |
US10444179B2 (en) | 2016-08-10 | 2019-10-15 | Multerra Bio, Inc. | Apparatuses and methods for detecting molecules and binding energy |
US9816988B1 (en) | 2016-08-10 | 2017-11-14 | Multerra Bio, Inc. | Apparatuses and methods for detecting molecules and binding energy |
RU2019108155A (en) | 2016-08-22 | 2020-09-21 | Рамот Эт Тель-Авив Юниверсити Лтд. | METHOD AND SYSTEM FOR SUBCUTANEOUS SENSOR DETECTION |
EP3500857B1 (en) | 2016-08-22 | 2023-10-04 | Ramot at Tel-Aviv University Ltd. | Methods and systems for detecting bioanalytes |
US11715772B1 (en) * | 2016-08-30 | 2023-08-01 | Femtodx, Inc. | Field-controlled sensor architecture and related methods |
US11209416B2 (en) | 2017-07-28 | 2021-12-28 | Graphene-Dx, Inc. | Device and method for chemical analysis |
WO2019148167A1 (en) | 2018-01-29 | 2019-08-01 | Rite Taste, LLC | Methods and devices for detection of pathogens |
US12055543B2 (en) | 2018-05-24 | 2024-08-06 | Graphene-Dx, Inc. | Methods and devices for detection of THC |
US11056602B2 (en) | 2019-06-20 | 2021-07-06 | United States Of America As Represented By The Secretary Of The Navy | Device, system, and method for selectively tuning nanoparticles with graphene |
Family Cites Families (249)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US905586A (en) | 1908-03-14 | 1908-12-01 | Mcloughlin Brothers | Disk propeller or game apparatus. |
US3873360A (en) * | 1971-11-26 | 1975-03-25 | Western Electric Co | Method of depositing a metal on a surface of a substrate |
US3873359A (en) * | 1971-11-26 | 1975-03-25 | Western Electric Co | Method of depositing a metal on a surface of a substrate |
US3900614A (en) | 1971-11-26 | 1975-08-19 | Western Electric Co | Method of depositing a metal on a surface of a substrate |
US4341009A (en) | 1980-12-05 | 1982-07-27 | International Business Machines Corporation | Method for making an electrical contact to a silicon substrate through a relatively thin layer of silicon dioxide on the surface of the substrate |
US6846654B1 (en) | 1983-11-29 | 2005-01-25 | Igen International, Inc. | Catalytic antibodies as chemical sensors |
JPS6194042A (en) * | 1984-10-16 | 1986-05-12 | Matsushita Electric Ind Co Ltd | Molecular construction and its manufacture |
US4939556A (en) | 1986-07-10 | 1990-07-03 | Canon Kabushiki Kaisha | Conductor device |
US5089545A (en) * | 1989-02-12 | 1992-02-18 | Biotech International, Inc. | Switching and memory elements from polyamino acids and the method of their assembly |
US5023139A (en) * | 1989-04-04 | 1991-06-11 | Research Corporation Technologies, Inc. | Nonlinear optical materials |
JPH05501928A (en) | 1989-10-18 | 1993-04-08 | リサーチ コーポレーション テクノロジーズ インコーポレーテッド | Coated particles and methods of coating particles |
US5332910A (en) | 1991-03-22 | 1994-07-26 | Hitachi, Ltd. | Semiconductor optical device with nanowhiskers |
US5274602A (en) | 1991-10-22 | 1993-12-28 | Florida Atlantic University | Large capacity solid-state memory |
JP3243303B2 (en) * | 1991-10-28 | 2002-01-07 | ゼロックス・コーポレーション | Quantum confined semiconductor light emitting device and method of manufacturing the same |
US5475341A (en) | 1992-06-01 | 1995-12-12 | Yale University | Sub-nanoscale electronic systems and devices |
US5252835A (en) | 1992-07-17 | 1993-10-12 | President And Trustees Of Harvard College | Machining oxide thin-films with an atomic force microscope: pattern and object formation on the nanometer scale |
EP0622439A1 (en) | 1993-04-20 | 1994-11-02 | Koninklijke Philips Electronics N.V. | Quantum sized activator doped semiconductor particles |
US5453970A (en) | 1993-07-13 | 1995-09-26 | Rust; Thomas F. | Molecular memory medium and molecular memory disk drive for storing information using a tunnelling probe |
WO1995002709A2 (en) | 1993-07-15 | 1995-01-26 | President And Fellows Of Harvard College | EXTENDED NITRIDE MATERIAL COMPRISING β-C3N¿4? |
US5512131A (en) * | 1993-10-04 | 1996-04-30 | President And Fellows Of Harvard College | Formation of microstamped patterns on surfaces and derivative articles |
US5900160A (en) * | 1993-10-04 | 1999-05-04 | President And Fellows Of Harvard College | Methods of etching articles via microcontact printing |
US5776748A (en) | 1993-10-04 | 1998-07-07 | President And Fellows Of Harvard College | Method of formation of microstamped patterns on plates for adhesion of cells and other biological materials, devices and uses therefor |
US6180239B1 (en) * | 1993-10-04 | 2001-01-30 | President And Fellows Of Harvard College | Microcontact printing on surfaces and derivative articles |
US5936703A (en) | 1993-10-13 | 1999-08-10 | Nof Corporation | Alkoxysilane compound, surface processing solution and contact lens |
JP3254865B2 (en) | 1993-12-17 | 2002-02-12 | ソニー株式会社 | Camera device |
EP0659911A1 (en) | 1993-12-23 | 1995-06-28 | International Business Machines Corporation | Method to form a polycrystalline film on a substrate |
US5599677A (en) | 1993-12-29 | 1997-02-04 | Abbott Laboratories | Immunoassays for prostate specific antigen |
JP3460096B2 (en) | 1994-05-30 | 2003-10-27 | 富士通株式会社 | Method for manufacturing semiconductor device |
US5620850A (en) | 1994-09-26 | 1997-04-15 | President And Fellows Of Harvard College | Molecular recognition at surfaces derivatized with self-assembled monolayers |
WO1996014206A1 (en) * | 1994-11-08 | 1996-05-17 | Spectra Science Corporation | Semiconductor nanocrystal display materials and display apparatus employing same |
US5581091A (en) | 1994-12-01 | 1996-12-03 | Moskovits; Martin | Nanoelectric devices |
US5866434A (en) | 1994-12-08 | 1999-02-02 | Meso Scale Technology | Graphitic nanotubes in luminescence assays |
US5539214A (en) | 1995-02-06 | 1996-07-23 | Regents Of The University Of California | Quantum bridges fabricated by selective etching of superlattice structures |
US5524092A (en) * | 1995-02-17 | 1996-06-04 | Park; Jea K. | Multilayered ferroelectric-semiconductor memory-device |
WO1996029629A2 (en) | 1995-03-01 | 1996-09-26 | President And Fellows Of Harvard College | Microcontact printing on surfaces and derivative articles |
EP0821726B1 (en) | 1995-03-10 | 2014-05-07 | Meso Scale Technologies, LLC. | Multi-array, multi-specific electrochemiluminescence testing |
US5747180A (en) * | 1995-05-19 | 1998-05-05 | University Of Notre Dame Du Lac | Electrochemical synthesis of quasi-periodic quantum dot and nanostructure arrays |
US5824470A (en) | 1995-05-30 | 1998-10-20 | California Institute Of Technology | Method of preparing probes for sensing and manipulating microscopic environments and structures |
US5751156A (en) * | 1995-06-07 | 1998-05-12 | Yale University | Mechanically controllable break transducer |
US6190634B1 (en) * | 1995-06-07 | 2001-02-20 | President And Fellows Of Harvard College | Carbide nanomaterials |
US5757038A (en) * | 1995-11-06 | 1998-05-26 | International Business Machines Corporation | Self-aligned dual gate MOSFET with an ultranarrow channel |
WO1997019208A1 (en) * | 1995-11-22 | 1997-05-29 | Northwestern University | Method of encapsulating a material in a carbon nanotube |
JP2904090B2 (en) | 1996-01-10 | 1999-06-14 | 日本電気株式会社 | Single electronic device |
US6036774A (en) * | 1996-02-26 | 2000-03-14 | President And Fellows Of Harvard College | Method of producing metal oxide nanorods |
US5897945A (en) * | 1996-02-26 | 1999-04-27 | President And Fellows Of Harvard College | Metal oxide nanorods |
CN1217653A (en) | 1996-03-06 | 1999-05-26 | 海珀里昂催化国际有限公司 | Functionalized nanotubes |
DE19610115C2 (en) | 1996-03-14 | 2000-11-23 | Fraunhofer Ges Forschung | Detection of molecules and molecular complexes |
US6355198B1 (en) * | 1996-03-15 | 2002-03-12 | President And Fellows Of Harvard College | Method of forming articles including waveguides via capillary micromolding and microtransfer molding |
US6060121A (en) * | 1996-03-15 | 2000-05-09 | President And Fellows Of Harvard College | Microcontact printing of catalytic colloids |
WO1997033737A1 (en) | 1996-03-15 | 1997-09-18 | President And Fellows Of Harvard College | Method of forming articles and patterning surfaces via capillary micromolding |
US5640343A (en) * | 1996-03-18 | 1997-06-17 | International Business Machines Corporation | Magnetic memory array using magnetic tunnel junction devices in the memory cells |
RU2099808C1 (en) | 1996-04-01 | 1997-12-20 | Евгений Инвиевич Гиваргизов | Process of growing of oriented systems of whiskers and gear for its implementation ( versions ) |
US5942443A (en) | 1996-06-28 | 1999-08-24 | Caliper Technologies Corporation | High throughput screening assay systems in microscale fluidic devices |
JPH09298284A (en) * | 1996-05-09 | 1997-11-18 | Nec Corp | Method for forming semiconductor capacitive element |
US5726524A (en) * | 1996-05-31 | 1998-03-10 | Minnesota Mining And Manufacturing Company | Field emission device having nanostructured emitters |
WO1998005920A1 (en) | 1996-08-08 | 1998-02-12 | William Marsh Rice University | Macroscopically manipulable nanoscale devices made from nanotube assemblies |
US6118492A (en) * | 1996-08-14 | 2000-09-12 | Starsight Telecast, Inc. | Guide system and method of operation |
JPH10106960A (en) | 1996-09-25 | 1998-04-24 | Sony Corp | Manufacture of quantum thin line |
JP3858319B2 (en) | 1996-12-05 | 2006-12-13 | ソニー株式会社 | Quantum wire manufacturing method |
US6038060A (en) * | 1997-01-16 | 2000-03-14 | Crowley; Robert Joseph | Optical antenna array for harmonic generation, mixing and signal amplification |
US5908692A (en) * | 1997-01-23 | 1999-06-01 | Wisconsin Alumni Research Foundation | Ordered organic monolayers and methods of preparation thereof |
US6008777A (en) | 1997-03-07 | 1999-12-28 | Intel Corporation | Wireless connectivity between a personal computer and a television |
US5997832A (en) | 1997-03-07 | 1999-12-07 | President And Fellows Of Harvard College | Preparation of carbide nanorods |
CA2283502C (en) | 1997-03-07 | 2005-06-14 | William Marsh Rice University | Carbon fibers formed from singlewall carbon nanotubes |
JP3183845B2 (en) | 1997-03-21 | 2001-07-09 | 財団法人ファインセラミックスセンター | Method for producing carbon nanotube and carbon nanotube film |
US5847565A (en) | 1997-03-31 | 1998-12-08 | Council Of Scientific And Industrial Research | Logic device |
US6359288B1 (en) * | 1997-04-24 | 2002-03-19 | Massachusetts Institute Of Technology | Nanowire arrays |
US5864823A (en) * | 1997-06-25 | 1999-01-26 | Virtel Corporation | Integrated virtual telecommunication system for E-commerce |
US6069380A (en) * | 1997-07-25 | 2000-05-30 | Regents Of The University Of Minnesota | Single-electron floating-gate MOS memory |
US7001996B1 (en) | 1997-08-21 | 2006-02-21 | The United States Of America As Represented By The Secretary Of The Army | Enzymatic template polymerization |
US20050147991A1 (en) | 1997-08-21 | 2005-07-07 | Samuelson Lynne A. | Enzymatic template polymerization |
US6187165B1 (en) * | 1997-10-02 | 2001-02-13 | The John Hopkins University | Arrays of semi-metallic bismuth nanowires and fabrication techniques therefor |
US5903010A (en) * | 1997-10-29 | 1999-05-11 | Hewlett-Packard Company | Quantum wire switch and switching method |
JP3740295B2 (en) | 1997-10-30 | 2006-02-01 | キヤノン株式会社 | Carbon nanotube device, manufacturing method thereof, and electron-emitting device |
US6004444A (en) | 1997-11-05 | 1999-12-21 | The Trustees Of Princeton University | Biomimetic pathways for assembling inorganic thin films and oriented mesoscopic silicate patterns through guided growth |
US20030135971A1 (en) | 1997-11-12 | 2003-07-24 | Michael Liberman | Bundle draw based processing of nanofibers and method of making |
US6762056B1 (en) | 1997-11-12 | 2004-07-13 | Protiveris, Inc. | Rapid method for determining potential binding sites of a protein |
US6123819A (en) | 1997-11-12 | 2000-09-26 | Protiveris, Inc. | Nanoelectrode arrays |
US5985173A (en) | 1997-11-18 | 1999-11-16 | Gray; Henry F. | Phosphors having a semiconductor host surrounded by a shell |
US6207392B1 (en) * | 1997-11-25 | 2001-03-27 | The Regents Of The University Of California | Semiconductor nanocrystal probes for biological applications and process for making and using such probes |
JP3902883B2 (en) | 1998-03-27 | 2007-04-11 | キヤノン株式会社 | Nanostructure and manufacturing method thereof |
US6287765B1 (en) | 1998-05-20 | 2001-09-11 | Molecular Machines, Inc. | Methods for detecting and identifying single molecules |
JP2000041320A (en) * | 1998-05-20 | 2000-02-08 | Yazaki Corp | Grommet |
EP0962773A1 (en) | 1998-06-03 | 1999-12-08 | Mark Howard Jones | Electrochemical based assay processes instrument and labels |
US6159742A (en) | 1998-06-05 | 2000-12-12 | President And Fellows Of Harvard College | Nanometer-scale microscopy probes |
US6203864B1 (en) * | 1998-06-08 | 2001-03-20 | Nec Corporation | Method of forming a heterojunction of a carbon nanotube and a different material, method of working a filament of a nanotube |
US6346189B1 (en) | 1998-08-14 | 2002-02-12 | The Board Of Trustees Of The Leland Stanford Junior University | Carbon nanotube structures made using catalyst islands |
US7416699B2 (en) | 1998-08-14 | 2008-08-26 | The Board Of Trustees Of The Leland Stanford Junior University | Carbon nanotube devices |
CN100368287C (en) | 1998-09-18 | 2008-02-13 | 威廉马歇莱思大学 | Chemical derivatization of single-walled carbon nanotubes to facilitate their solvation and uses of derivatized nanotubes |
DE69938353T2 (en) | 1998-09-24 | 2009-03-05 | Indiana University Research and Technology Corp., Indianapolis | WATER-SOLUBLE LUMINESCENT QUANTUM-DOTS AND THEIR BIOKON JUGATE |
WO2000019494A1 (en) | 1998-09-28 | 2000-04-06 | Xidex Corporation | Method for manufacturing carbon nanotubes as functional elements of mems devices |
US6705152B2 (en) | 2000-10-24 | 2004-03-16 | Nanoproducts Corporation | Nanostructured ceramic platform for micromachined devices and device arrays |
US6468657B1 (en) | 1998-12-04 | 2002-10-22 | The Regents Of The University Of California | Controllable ion-exchange membranes |
JP3754568B2 (en) | 1999-01-29 | 2006-03-15 | シャープ株式会社 | Quantum wire manufacturing method |
US20020013031A1 (en) * | 1999-02-09 | 2002-01-31 | Kuen-Jian Chen | Method of improving the reliability of gate oxide layer |
KR100679547B1 (en) | 1999-02-22 | 2007-02-07 | 조셉 이. 쥬니어 클로손 | Microstructured Devices and Devices |
US6143184A (en) | 1999-03-02 | 2000-11-07 | United States Filter Corporation | Air and water purification using continuous breakpoint halogenation |
US6149819A (en) | 1999-03-02 | 2000-11-21 | United States Filter Corporation | Air and water purification using continuous breakpoint halogenation and peroxygenation |
US6314019B1 (en) | 1999-03-29 | 2001-11-06 | Hewlett-Packard Company | Molecular-wire crossbar interconnect (MWCI) for signal routing and communications |
US6459095B1 (en) | 1999-03-29 | 2002-10-01 | Hewlett-Packard Company | Chemically synthesized and assembled electronics devices |
US6128214A (en) | 1999-03-29 | 2000-10-03 | Hewlett-Packard | Molecular wire crossbar memory |
US6256767B1 (en) | 1999-03-29 | 2001-07-03 | Hewlett-Packard Company | Demultiplexer for a molecular wire crossbar network (MWCN DEMUX) |
US7030408B1 (en) * | 1999-03-29 | 2006-04-18 | Hewlett-Packard Development Company, L.P. | Molecular wire transistor (MWT) |
US6270074B1 (en) | 1999-04-14 | 2001-08-07 | Hewlett-Packard Company | Print media vacuum holddown |
AUPP976499A0 (en) | 1999-04-16 | 1999-05-06 | Commonwealth Scientific And Industrial Research Organisation | Multilayer carbon nanotube films |
US20030124509A1 (en) | 1999-06-03 | 2003-07-03 | Kenis Paul J.A. | Laminar flow patterning and articles made thereby |
DE60044972D1 (en) | 1999-07-02 | 2010-10-28 | Harvard College | NANOSCOPIC WIRE CONTAINING ARRANGEMENT, LOGISC |
US6322713B1 (en) | 1999-07-15 | 2001-11-27 | Agere Systems Guardian Corp. | Nanoscale conductive connectors and method for making same |
US6538367B1 (en) * | 1999-07-15 | 2003-03-25 | Agere Systems Inc. | Field emitting device comprising field-concentrating nanoconductor assembly and method for making the same |
US6465132B1 (en) | 1999-07-22 | 2002-10-15 | Agere Systems Guardian Corp. | Article comprising small diameter nanowires and method for making the same |
US6286226B1 (en) | 1999-09-24 | 2001-09-11 | Agere Systems Guardian Corp. | Tactile sensor comprising nanowires and method for making the same |
US6340822B1 (en) * | 1999-10-05 | 2002-01-22 | Agere Systems Guardian Corp. | Article comprising vertically nano-interconnected circuit devices and method for making the same |
US6741019B1 (en) * | 1999-10-18 | 2004-05-25 | Agere Systems, Inc. | Article comprising aligned nanowires |
US6437329B1 (en) | 1999-10-27 | 2002-08-20 | Advanced Micro Devices, Inc. | Use of carbon nanotubes as chemical sensors by incorporation of fluorescent molecules within the tube |
US20050037374A1 (en) * | 1999-11-08 | 2005-02-17 | Melker Richard J. | Combined nanotechnology and sensor technologies for simultaneous diagnosis and treatment |
US6974706B1 (en) | 2003-01-16 | 2005-12-13 | University Of Florida Research Foundation, Inc. | Application of biosensors for diagnosis and treatment of disease |
JP2003517604A (en) | 1999-12-15 | 2003-05-27 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | Carbon nanotube device |
US6248674B1 (en) * | 2000-02-02 | 2001-06-19 | Hewlett-Packard Company | Method of aligning nanowires |
US7186355B2 (en) * | 2000-02-04 | 2007-03-06 | Massachusetts Institute Of Technology | Insulated nanoscopic pathways, compositions and devices of the same |
US6503375B1 (en) * | 2000-02-11 | 2003-01-07 | Applied Materials, Inc | Electroplating apparatus using a perforated phosphorus doped consumable anode |
US6294450B1 (en) | 2000-03-01 | 2001-09-25 | Hewlett-Packard Company | Nanoscale patterning for the formation of extensive wires |
EP1268087A4 (en) * | 2000-03-22 | 2007-05-23 | Univ Massachusetts | MATRIZE FROM NANO CYLINDERS |
US6720240B2 (en) | 2000-03-29 | 2004-04-13 | Georgia Tech Research Corporation | Silicon based nanospheres and nanowires |
JP4089122B2 (en) | 2000-03-31 | 2008-05-28 | 株式会社リコー | Contact charger manufacturing method, contact charger obtained by the method, charging method and image recording apparatus |
US7323143B2 (en) | 2000-05-25 | 2008-01-29 | President And Fellows Of Harvard College | Microfluidic systems including three-dimensionally arrayed channel networks |
US6440637B1 (en) | 2000-06-28 | 2002-08-27 | The Aerospace Corporation | Electron beam lithography method forming nanocrystal shadowmasks and nanometer etch masks |
EP1170799A3 (en) | 2000-07-04 | 2009-04-01 | Infineon Technologies AG | Electronic device and method of manufacture of an electronic device |
AU2001282977A1 (en) | 2000-07-26 | 2002-02-05 | The Burnham Institute | Screening methods based on superactivated alphavbeta3 integrin |
US6468677B1 (en) | 2000-08-01 | 2002-10-22 | Premark Rwp Holdings Inc. | Electroluminescent high pressure laminate |
US7301199B2 (en) | 2000-08-22 | 2007-11-27 | President And Fellows Of Harvard College | Nanoscale wires and related devices |
US20060175601A1 (en) * | 2000-08-22 | 2006-08-10 | President And Fellows Of Harvard College | Nanoscale wires and related devices |
EP2298968A3 (en) * | 2000-08-22 | 2011-10-05 | President and Fellows of Harvard College | Method for growing nanowires |
US6465331B1 (en) | 2000-08-31 | 2002-10-15 | Micron Technology, Inc. | DRAM fabricated on a silicon-on-insulator (SOI) substrate having bi-level digit lines |
WO2002021576A2 (en) | 2000-09-07 | 2002-03-14 | Ramot University Authority For Applied Research & Industrial Development Ltd. | Organic nanoelectric conductors |
US20020146714A1 (en) | 2000-09-11 | 2002-10-10 | Lieber Charles M. | Direct haplotyping using carbon nanotube probes |
WO2002022499A1 (en) * | 2000-09-18 | 2002-03-21 | President And Fellows Of Harvard College | Fabrication of nanotube microscopy tips |
WO2002026624A1 (en) | 2000-09-29 | 2002-04-04 | President And Fellows Of Harvard College | Direct growth of nanotubes, and their use in nanotweezers |
CN1468316A (en) | 2000-10-10 | 2004-01-14 | �ݰĸ�˹����ѧ����˾ | Nanoscale sensor |
US6413802B1 (en) | 2000-10-23 | 2002-07-02 | The Regents Of The University Of California | Finfet transistor structures having a double gate channel extending vertically from a substrate and methods of manufacture |
JP3811004B2 (en) * | 2000-11-26 | 2006-08-16 | 喜萬 中山 | Conductive scanning microscope probe |
ES2312490T3 (en) * | 2000-12-11 | 2009-03-01 | President And Fellows Of Harvard College | DEVICE CONTAINING MANOSENSORS TO DETECT AN ANALYTE AND ITS MANUFACTURING METHOD. |
US20020084502A1 (en) | 2000-12-29 | 2002-07-04 | Jin Jang | Carbon nanotip and fabricating method thereof |
WO2002079514A1 (en) | 2001-01-10 | 2002-10-10 | The Trustees Of Boston College | Dna-bridged carbon nanotube arrays |
US6586095B2 (en) | 2001-01-12 | 2003-07-01 | Georgia Tech Research Corp. | Semiconducting oxide nanostructures |
WO2002093738A2 (en) | 2001-01-19 | 2002-11-21 | California Institute Of Technology | Carbon nanobimorph actuator and sensor |
US7189435B2 (en) | 2001-03-14 | 2007-03-13 | University Of Massachusetts | Nanofabrication |
US8029734B2 (en) * | 2001-03-29 | 2011-10-04 | The Board Of Trustees Of The Leland Stanford Junior University | Noncovalent sidewall functionalization of carbon nanotubes |
US6803840B2 (en) | 2001-03-30 | 2004-10-12 | California Institute Of Technology | Pattern-aligned carbon nanotube growth and tunable resonator apparatus |
AU2002307008C1 (en) * | 2001-03-30 | 2008-10-30 | The Regents Of The University Of California | Methods of fabricating nanostructures and nanowires and devices fabricated therefrom |
US20020146745A1 (en) | 2001-04-03 | 2002-10-10 | Surromed, Inc. | Methods and reagents for multiplexed analyte capture, surface array self-assembly, and analysis of complex biological samples |
US7459312B2 (en) | 2001-04-18 | 2008-12-02 | The Board Of Trustees Of The Leland Stanford Junior University | Photodesorption in carbon nanotubes |
US7232460B2 (en) * | 2001-04-25 | 2007-06-19 | Xillus, Inc. | Nanodevices, microdevices and sensors on in-vivo structures and method for the same |
US6902720B2 (en) | 2001-05-10 | 2005-06-07 | Worcester Polytechnic Institute | Cyclic peptide structures for molecular scale electronic and photonic devices |
US7132275B2 (en) | 2001-05-14 | 2006-11-07 | The John Hopkins University | Multifunctional magnetic nanowires |
JP2004535066A (en) | 2001-05-18 | 2004-11-18 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | Nanoscale wires and related devices |
US20030129087A1 (en) | 2001-06-13 | 2003-07-10 | The Regents Of The University Of California | Ordered adsorbed layers of nano particulate materials on structured nano-laminate templates |
US20030048619A1 (en) * | 2001-06-15 | 2003-03-13 | Kaler Eric W. | Dielectrophoretic assembling of electrically functional microwires |
US6846565B2 (en) * | 2001-07-02 | 2005-01-25 | Board Of Regents, The University Of Texas System | Light-emitting nanoparticles and method of making same |
US20030113940A1 (en) * | 2001-07-16 | 2003-06-19 | Erlanger Bernard F. | Antibodies specific for nanotubes and related methods and compositions |
CA2454272C (en) | 2001-07-20 | 2010-03-30 | President And Fellows Of Harvard College | Transition metal oxide nanowires, and devices incorporating them |
KR100455284B1 (en) | 2001-08-14 | 2004-11-12 | 삼성전자주식회사 | High-throughput sensor for detecting biomolecules using carbon nanotubes |
AU2002333526B2 (en) * | 2001-09-10 | 2008-01-17 | Meso Scale Technologies, Llc. | Methods and apparatus for conducting multiple measurements on a sample |
US7482168B2 (en) * | 2001-09-15 | 2009-01-27 | The Regents Of The University Of California | Photoluminescent polymetalloles as chemical sensors |
US20030073071A1 (en) * | 2001-10-12 | 2003-04-17 | Jurgen Fritz | Solid state sensing system and method for measuring the binding or hybridization of biomolecules |
EP1456634A1 (en) * | 2001-11-26 | 2004-09-15 | Sony International (Europe) GmbH | The use of 1d semiconductor materials as chemical sensing materials, produced and operated close to room temperature |
US20030124717A1 (en) | 2001-11-26 | 2003-07-03 | Yuji Awano | Method of manufacturing carbon cylindrical structures and biopolymer detection device |
US7385262B2 (en) * | 2001-11-27 | 2008-06-10 | The Board Of Trustees Of The Leland Stanford Junior University | Band-structure modulation of nano-structures in an electric field |
WO2003054931A1 (en) | 2001-12-12 | 2003-07-03 | Jorma Virtanen | Method and apparatus for nano-sensing |
US6882767B2 (en) * | 2001-12-27 | 2005-04-19 | The Regents Of The University Of California | Nanowire optoelectric switching device and method |
US20030134433A1 (en) | 2002-01-16 | 2003-07-17 | Nanomix, Inc. | Electronic sensing of chemical and biological agents using functionalized nanostructures |
EP1468423A2 (en) | 2002-01-18 | 2004-10-20 | California Institute Of Technology | Array-based architecture for molecular electronics |
US7351313B2 (en) | 2002-03-08 | 2008-04-01 | National Institute Of Information And Communications Technology, Incorporated Administrative Agency | Production device and production method for conductive nano-wire |
CN1444259A (en) | 2002-03-12 | 2003-09-24 | 株式会社东芝 | Method for mfg. semiconductor device |
US6822051B2 (en) | 2002-03-29 | 2004-11-23 | Media Plus, Inc. | High density polyethylene melt blends for improved stress crack resistance in pipe |
US6872645B2 (en) | 2002-04-02 | 2005-03-29 | Nanosys, Inc. | Methods of positioning and/or orienting nanostructures |
US20040026684A1 (en) * | 2002-04-02 | 2004-02-12 | Nanosys, Inc. | Nanowire heterostructures for encoding information |
US20030189202A1 (en) | 2002-04-05 | 2003-10-09 | Jun Li | Nanowire devices and methods of fabrication |
US20040067530A1 (en) * | 2002-05-08 | 2004-04-08 | The Regents Of The University Of California | Electronic sensing of biomolecular processes |
AU2003258969A1 (en) | 2002-06-27 | 2004-01-19 | Nanosys Inc. | Planar nanowire based sensor elements, devices, systems and methods for using and making same |
US7335908B2 (en) * | 2002-07-08 | 2008-02-26 | Qunano Ab | Nanostructures and methods for manufacturing the same |
WO2004010552A1 (en) | 2002-07-19 | 2004-01-29 | President And Fellows Of Harvard College | Nanoscale coherent optical components |
EP1758126A3 (en) * | 2002-07-25 | 2007-03-14 | California Institute Of Technology | Nanoscale selection circuit |
JP2006516335A (en) | 2002-08-21 | 2006-06-29 | ニューヨーク・ユニバーシティ | Brain-machine interface system and method |
EP2399970A3 (en) * | 2002-09-05 | 2012-04-18 | Nanosys, Inc. | Nanocomposites |
US7572393B2 (en) * | 2002-09-05 | 2009-08-11 | Nanosys Inc. | Organic species that facilitate charge transfer to or from nanostructures |
JP2005538573A (en) | 2002-09-05 | 2005-12-15 | ナノシス・インク. | Compositions based on nanostructures and nanocomposites |
WO2004027822A2 (en) | 2002-09-05 | 2004-04-01 | Nanosys, Inc. | Oriented nanostructures and methods of preparing |
WO2004027093A1 (en) | 2002-09-19 | 2004-04-01 | The Chancellor, Master And Scholars Of The University Of Oxford | Molecular arrays and single molecule detection |
EP1547139A4 (en) | 2002-09-30 | 2009-08-26 | Nanosys Inc | MACRO-ELECTRONIC SUBSTRATE WITH HIGH NANO-ACTIVATION SURFACE AREA AND USES THEREOF |
US7067867B2 (en) * | 2002-09-30 | 2006-06-27 | Nanosys, Inc. | Large-area nonenabled macroelectronic substrates and uses therefor |
US7135728B2 (en) | 2002-09-30 | 2006-11-14 | Nanosys, Inc. | Large-area nanoenabled macroelectronic substrates and uses therefor |
US7051945B2 (en) | 2002-09-30 | 2006-05-30 | Nanosys, Inc | Applications of nano-enabled large area macroelectronic substrates incorporating nanowires and nanowire composites |
US7102605B2 (en) | 2002-09-30 | 2006-09-05 | Nanosys, Inc. | Integrated displays using nanowire transistors |
US7303875B1 (en) | 2002-10-10 | 2007-12-04 | Nanosys, Inc. | Nano-chem-FET based biosensors |
DE10250984A1 (en) | 2002-10-29 | 2004-05-19 | Hahn-Meitner-Institut Berlin Gmbh | Field effect transistor and method for its production |
US7163659B2 (en) * | 2002-12-03 | 2007-01-16 | Hewlett-Packard Development Company, L.P. | Free-standing nanowire sensor and method for detecting an analyte in a fluid |
US7355216B2 (en) | 2002-12-09 | 2008-04-08 | The Regents Of The University Of California | Fluidic nanotubes and devices |
US6815706B2 (en) | 2002-12-17 | 2004-11-09 | Hewlett-Packard Development Company, L.P. | Nano optical sensors via molecular self-assembly |
WO2004099307A2 (en) | 2003-02-07 | 2004-11-18 | Wisconsin Alumni Research Foundation | Nanocylinder-modified surfaces |
US20040191517A1 (en) | 2003-03-26 | 2004-09-30 | Industrial Technology Research Institute | Self-assembling nanowires |
SE0301236D0 (en) | 2003-04-28 | 2003-04-28 | Chalmers Technology Licensing | Method of manufacturing a nanoscale conductive device |
US7741033B2 (en) | 2003-05-13 | 2010-06-22 | Trustees Of Boston College | Electrocatalytic nucleic acid hybridization detection |
WO2004109706A2 (en) | 2003-06-02 | 2004-12-16 | California Institute Of Technology | Nanoscale wire-based sublithographic programmable logic arrays |
WO2004109282A1 (en) | 2003-06-10 | 2004-12-16 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Electronic device for communication with living cells |
US20050079591A1 (en) | 2003-07-08 | 2005-04-14 | Reich Daniel H. | Method and magnetic microarray system for trapping and manipulating cells |
KR101132076B1 (en) * | 2003-08-04 | 2012-04-02 | 나노시스, 인크. | System and process for producing nanowire composites and electronic substrates therefrom |
WO2005084534A1 (en) | 2003-09-03 | 2005-09-15 | Life Patch International, Inc. | Personal diagnostic devices and related methods |
US7067328B2 (en) * | 2003-09-25 | 2006-06-27 | Nanosys, Inc. | Methods, devices and compositions for depositing and orienting nanostructures |
US20050253137A1 (en) | 2003-11-20 | 2005-11-17 | President And Fellows Of Harvard College | Nanoscale arrays, robust nanostructures, and related devices |
US7662706B2 (en) * | 2003-11-26 | 2010-02-16 | Qunano Ab | Nanostructures formed of branched nanowhiskers and methods of producing the same |
US7181836B2 (en) | 2003-12-19 | 2007-02-27 | General Electric Company | Method for making an electrode structure |
US20090227107A9 (en) * | 2004-02-13 | 2009-09-10 | President And Fellows Of Havard College | Nanostructures Containing Metal Semiconductor Compounds |
WO2005093831A1 (en) | 2004-02-13 | 2005-10-06 | President And Fellows Of Harvard College | Nanostructures containing metal-semiconductor compounds |
US20050202615A1 (en) | 2004-03-10 | 2005-09-15 | Nanosys, Inc. | Nano-enabled memory devices and anisotropic charge carrying arrays |
EP1723676A4 (en) | 2004-03-10 | 2009-04-15 | Nanosys Inc | MEMORY DEVICES WITH NANOCAPACITIES AND ANISOTROPIC LOADED NETWORKS |
US7595528B2 (en) | 2004-03-10 | 2009-09-29 | Nanosys, Inc. | Nano-enabled memory devices and anisotropic charge carrying arrays |
US7057881B2 (en) | 2004-03-18 | 2006-06-06 | Nanosys, Inc | Nanofiber surface based capacitors |
US7115971B2 (en) | 2004-03-23 | 2006-10-03 | Nanosys, Inc. | Nanowire varactor diode and methods of making same |
US7312155B2 (en) | 2004-04-07 | 2007-12-25 | Intel Corporation | Forming self-aligned nano-electrodes |
CN101010780B (en) * | 2004-04-30 | 2012-07-25 | 纳米系统公司 | Systems and methods for nanowire growth and harvesting |
WO2005114282A2 (en) | 2004-05-13 | 2005-12-01 | The Regents Of The University Of California | Nanowires and nanoribbons as subwavelength optical waveguides and their use as components in photonic circuits and devices |
US20050257821A1 (en) | 2004-05-19 | 2005-11-24 | Shriram Ramanathan | Thermoelectric nano-wire devices |
US7129154B2 (en) | 2004-05-28 | 2006-10-31 | Agilent Technologies, Inc | Method of growing semiconductor nanowires with uniform cross-sectional area using chemical vapor deposition |
US7501315B2 (en) | 2004-06-08 | 2009-03-10 | Nanosys, Inc. | Methods and devices for forming nanostructure monolayers and devices including such monolayers |
US7452778B2 (en) | 2004-06-10 | 2008-11-18 | Taiwan Semiconductor Manufacturing Company, Ltd. | Semiconductor nano-wire devices and methods of fabrication |
WO2006107312A1 (en) * | 2004-06-15 | 2006-10-12 | President And Fellows Of Harvard College | Nanosensors |
JP2008506254A (en) * | 2004-07-07 | 2008-02-28 | ナノシス・インコーポレイテッド | Systems and methods for nanowire integration and integration |
US8154002B2 (en) | 2004-12-06 | 2012-04-10 | President And Fellows Of Harvard College | Nanoscale wire-based data storage |
WO2006084128A2 (en) | 2005-02-04 | 2006-08-10 | Brown University | Apparatus, method and computer program product providing radial addressing of nanowires |
US20060269927A1 (en) | 2005-05-25 | 2006-11-30 | Lieber Charles M | Nanoscale sensors |
US20100227382A1 (en) | 2005-05-25 | 2010-09-09 | President And Fellows Of Harvard College | Nanoscale sensors |
WO2006132659A2 (en) | 2005-06-06 | 2006-12-14 | President And Fellows Of Harvard College | Nanowire heterostructures |
KR100741243B1 (en) | 2005-11-07 | 2007-07-19 | 삼성전자주식회사 | Nanowire Comprising Metal Nanodots and Method for Producing the Same |
CA2643997A1 (en) | 2006-03-15 | 2008-03-06 | President And Fellows Of Harvard College | Nanobioelectronics |
WO2007145701A2 (en) | 2006-04-07 | 2007-12-21 | President And Fellows Of Harvard College | Nanoscale wire methods and devices |
JP2009540333A (en) | 2006-06-12 | 2009-11-19 | プレジデント アンド フェロウズ オブ ハーバード カレッジ | Nanosensors and related technologies |
US8058640B2 (en) | 2006-09-11 | 2011-11-15 | President And Fellows Of Harvard College | Branched nanoscale wires |
WO2008123869A2 (en) | 2006-11-21 | 2008-10-16 | President And Fellows Of Harvard College | Millimeter-long nanowires |
US8575663B2 (en) | 2006-11-22 | 2013-11-05 | President And Fellows Of Harvard College | High-sensitivity nanoscale wire sensors |
US7647113B2 (en) | 2006-12-21 | 2010-01-12 | Ams Research Corporation | Electrode implantation in male external urinary sphincter |
WO2009104056A1 (en) | 2008-02-21 | 2009-08-27 | Claus Birger Sorensen | Biochip for electrophysiological measurements |
US9297796B2 (en) | 2009-09-24 | 2016-03-29 | President And Fellows Of Harvard College | Bent nanowires and related probing of species |
KR101724273B1 (en) | 2010-03-17 | 2017-04-07 | 더 보드 오브 트러스티즈 오브 더 유니버시티 오브 일리노이 | implantable biomedical devices on bioresorbable substrates |
US8580099B2 (en) | 2010-09-20 | 2013-11-12 | University Of South Carolina | InN nanowire based multifunctional nanocantilever sensors |
WO2012170630A2 (en) | 2011-06-10 | 2012-12-13 | President And Fellows Of Harvard College | Nanoscale wires, nanoscale wire fet devices, and nanotube-electronic hybrid devices for sensing and other applications |
TWI552751B (en) | 2011-06-20 | 2016-10-11 | H 朗德貝克公司 | Administration of 4-((1R,3S)-6-chloro-3-phenyl-dihydroindol-1-yl)-1,2,2-trimethyl-piperidin and its salts for the treatment of schizophrenia Methods |
US9638717B2 (en) | 2012-05-03 | 2017-05-02 | President And Fellows Of Harvard College | Nanoscale sensors for intracellular and other applications |
WO2014031709A1 (en) | 2012-08-24 | 2014-02-27 | President And Fellows Of Harvard College | Nanoscale wire probes |
JP2015535928A (en) | 2012-09-12 | 2015-12-17 | プレジデント アンド フェローズ オブ ハーバード カレッジ | Nanoscale field effect transistors for biomolecular sensors and other applications |
-
2007
- 2007-11-19 US US12/312,740 patent/US8575663B2/en not_active Expired - Fee Related
- 2007-11-19 WO PCT/US2007/024126 patent/WO2008127314A1/en active Application Filing
- 2007-11-19 EP EP07873479.5A patent/EP2095100B1/en not_active Not-in-force
-
2013
- 2013-09-18 US US14/030,170 patent/US9535063B2/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
See references of WO2008127314A1 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9488614B2 (en) | 2012-10-16 | 2016-11-08 | Abbott Laboratories | Localized desalting systems and methods |
Also Published As
Publication number | Publication date |
---|---|
US9535063B2 (en) | 2017-01-03 |
US20140080139A1 (en) | 2014-03-20 |
WO2008127314A1 (en) | 2008-10-23 |
US8575663B2 (en) | 2013-11-05 |
US20100152057A1 (en) | 2010-06-17 |
EP2095100B1 (en) | 2016-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9535063B2 (en) | High-sensitivity nanoscale wire sensors | |
JP4583710B2 (en) | Nano sensor | |
US9903862B2 (en) | Nanosensors and related technologies | |
US20070264623A1 (en) | Nanosensors | |
EP2434278A1 (en) | Apparatus for detecting one or more analytes comprising an elongated nano-structure and method for manufacturing said apparatus | |
US20060269927A1 (en) | Nanoscale sensors | |
US20100112546A1 (en) | Nanoscale sensors | |
AU2002229046A1 (en) | Nanosensors | |
US20180088079A1 (en) | Nanoscale wires with external layers for sensors and other applications | |
EP1736760A2 (en) | Nanosensors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20090617 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
17Q | First examination report despatched |
Effective date: 20090925 |
|
DAX | Request for extension of the european patent (deleted) | ||
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20130916 |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: PRESIDENT AND FELLOWS OF HARVARD COLLEGE |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
INTG | Intention to grant announced |
Effective date: 20160405 |
|
GRAS | Grant fee paid |
Free format text: ORIGINAL CODE: EPIDOSNIGR3 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC MT NL PL PT RO SE SI SK TR |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: EP |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: REF Ref document number: 831451 Country of ref document: AT Kind code of ref document: T Effective date: 20161015 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R096 Ref document number: 602007048041 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: FP |
|
REG | Reference to a national code |
Ref country code: LT Ref legal event code: MG4D Ref country code: FR Ref legal event code: PLFP Year of fee payment: 10 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160921 Ref country code: FI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160921 |
|
REG | Reference to a national code |
Ref country code: AT Ref legal event code: MK05 Ref document number: 831451 Country of ref document: AT Kind code of ref document: T Effective date: 20160921 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160921 Ref country code: GR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161222 Ref country code: LV Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160921 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: RO Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160921 Ref country code: EE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160921 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IS Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170121 Ref country code: BE Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160921 Ref country code: ES Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160921 Ref country code: SK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160921 Ref country code: CZ Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160921 Ref country code: BG Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20161221 Ref country code: AT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160921 Ref country code: PL Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160921 Ref country code: PT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20170123 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R097 Ref document number: 602007048041 Country of ref document: DE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160921 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DK Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160921 |
|
26N | No opposition filed |
Effective date: 20170622 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161130 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: PLFP Year of fee payment: 11 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SI Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160921 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: HU Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT; INVALID AB INITIO Effective date: 20071119 Ref country code: CY Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160921 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MC Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160921 Ref country code: TR Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT Effective date: 20160921 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: MT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20161119 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: NL Payment date: 20181126 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: IE Payment date: 20181126 Year of fee payment: 12 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20191127 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20191125 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20191203 Year of fee payment: 13 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20191127 Year of fee payment: 13 |
|
REG | Reference to a national code |
Ref country code: NL Ref legal event code: MM Effective date: 20191201 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191201 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20191119 |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: R119 Ref document number: 602007048041 Country of ref document: DE |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 20201119 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201130 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201130 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20210601 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20201119 |